###begin article-title 0
###xml 53 57 <span type="species:ncbi:10116">rats</span>
Cardiac contractile dysfunction in insulin-resistant rats fed a high-fat diet is associated with elevated CD36-mediated fatty acid uptake and esterification
###end article-title 0
###begin title 1
Aims/hypothesis
###end title 1
###begin p 2
###xml 284 288 <span type="species:ncbi:10116">rats</span>
Changes in cardiac substrate utilisation leading to altered energy metabolism may underlie the development of diabetic cardiomyopathy. We studied cardiomyocyte substrate uptake and utilisation and the role of the fatty acid translocase CD36 in relation to in vivo cardiac function in rats fed a high-fat diet (HFD).
###end p 2
###begin title 3
Methods
###end title 3
###begin p 4
###xml 0 4 <span type="species:ncbi:10116">Rats</span>
Rats were exposed to an HFD or a low-fat diet (LFD). In vivo cardiac function was monitored by echocardiography. Substrate uptake and utilisation were determined in isolated cardiomyocytes.
###end p 4
###begin title 5
Results
###end title 5
###begin p 6
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 527 528 527 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 635 636 635 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 314 318 <span type="species:ncbi:10116">rats</span>
Feeding an HFD for 8 weeks induced left ventricular dilation in the systolic phase and decreased fractional shortening and the ejection fraction. Insulin-stimulated glucose uptake and proline-rich Akt substrate 40 phosphorylation were 41% (p < 0.001) and 45% (p < 0.05) lower, respectively, in cardiomyocytes from rats on the HFD. However, long-chain fatty acid (LCFA) uptake was 1.4-fold increased (p < 0.001) and LCFA esterification into triacylglycerols and phospholipids was increased 1.4- and 1.5-fold, respectively (both p < 0.05), in cardiomyocytes from HFD compared with LFD hearts. In the presence of the CD36 inhibitor sulfo-N-succinimidyloleate, LCFA uptake and esterification were similar in LFD and HFD cardiomyocytes. In HFD hearts CD36 was relocated to the sarcolemma, and basal phosphorylation of a mediator of CD36-trafficking, i.e. protein kinase B (PKB/Akt), was increased.
###end p 6
###begin title 7
Conclusions/interpretation
###end title 7
###begin p 8
###xml 8 12 <span type="species:ncbi:10116">rats</span>
Feeding rats an HFD induced cardiac contractile dysfunction, which was accompanied by the relocation of CD36 to the sarcolemma, and elevated basal levels of phosphorylated PKB/Akt. The permanent presence of CD36 at the sarcolemma resulted in enhanced rates of LCFA uptake and myocardial triacylglycerol accumulation, and may contribute to the development of insulin resistance and diabetic cardiomyopathy.
###end p 8
###begin title 9
Electronic supplementary material
###end title 9
###begin p 10
The online version of this article (doi:10.1007/s00125-007-0735-8) contains supplementary material, which is available to authorised users.
###end p 10
###begin title 11
Keywords
###end title 11
###begin title 12
Introduction
###end title 12
###begin p 13
###xml 75 76 75 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 325 326 325 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR3">3</xref>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 417 422 417 418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</italic>
###xml 428 433 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</italic>
###xml 451 452 443 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 629 630 621 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 632 633 624 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 248 252 <span type="species:ncbi:10116">rats</span>
###xml 334 349 <span type="species:ncbi:10090">transgenic mice</span>
Diabetic cardiomyopathy (DCM) is a common complication in type 2 diabetes [1]. Changes in myocardial energy metabolism, due to altered substrate handling, characterise diabetes-related heart disease and DCM [1]. Studies in rodent models, including rats fed a high-fat diet (HFD) [2], leptin-deficient and -resistant animals [3-6] and transgenic mice with cardiac-restricted peroxisome proliferator activated receptor alpha (PPARalpha) overexpression [7], indicate that intramyocardial accumulation of triacylglycerol metabolites (lipotoxicity) and myocardial insulin resistance may underlie diabetes-related cardiac dysfunction [1, 8].
###end p 13
###begin p 14
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR6">6</xref>
###xml 127 128 127 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 229 231 229 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 736 738 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
Among the putative causes of myocardial triacylglycerol accumulation are elevations in long-chain fatty acid (LCFA) uptake [6, 7, 9]. In the heart, approximately 50% of LCFA uptake is mediated by the fatty acid translocase CD36 [10, 11]. Under physiological conditions, both insulin and contraction stimulate LCFA uptake by inducing the translocation of CD36 from an intracellular pool to the sarcolemma, illustrating that CD36 is also directly involved in the dynamic utilisation of LCFA by cardiomyocytes. This acute translocation of CD36 involves activation of phosphatidylinositol 3'-kinase (PI3K)/protein kinase B (PKB/Akt)- and AMP-kinase (AMPK)-dependent signalling cascades in response to insulin and contraction, respectively [11].
###end p 14
###begin p 15
###xml 208 209 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR7">7</xref>
###xml 302 304 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 703 704 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 706 708 702 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 1020 1022 1016 1018 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 1189 1190 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 142 157 <span type="species:ncbi:10090">transgenic mice</span>
###xml 619 623 <span type="species:ncbi:10116">rats</span>
###xml 1120 1124 <span type="species:ncbi:10116">rats</span>
Interestingly, CD36 deletion rescues the cardiac dysfunction, metabolic abnormalities and myocardial triacylglycerol accumulation observed in transgenic mice with cardiac-restricted PPARalpha overexpression [7], suggesting a critical role for CD36 in the development of diabetes-related heart disease [12]. We hypothesised that long-term alterations in the functional pool of CD36 lead to myocardial accumulation of (toxic) lipid metabolites and insulin resistance and contribute to the development of diabetes-related heart disease. To examine this, we first measured in vivo cardiac dimensions by echocardiography in rats exposed to a high-fat diet (HFD), which impairs myocardial insulin signalling [2, 13]. Subsequently, isolated cardiomyocytes were used to determine changes in substrate uptake and LCFA metabolism under basal conditions and after incubations with insulin and with oligomycin; the latter compound induces a contraction-like elevation of intracellular AMP levels and concomitant activation of AMPK [14]. Finally, we assessed whether the observed alterations could be ascribed to CD36 in hearts from rats on the HFD by analysing the effects of the CD36 inhibitor sulfo-N-succinimidyloleate (SSO) on myocardial LCFA uptake and utilisation in isolated cardiomyocytes, and by studying the expression and subcellular localisation of CD36 in cardiac ventricular tissue.
###end p 15
###begin title 16
Materials and methods
###end title 16
###begin p 17
###xml 0 7 0 7 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Animals</bold>
###xml 258 259 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 406 407 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 587 588 585 586 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 837 839 835 837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 252 256 <span type="species:ncbi:10116">rats</span>
###xml 421 425 <span type="species:ncbi:10116">rats</span>
###xml 688 692 <span type="species:ncbi:10116">Rats</span>
Animals The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the NIH (NIH Publication No. 85-23, revised 1996) and was approved by the VU University Medical Centre Animal Care Committee. Adult male Wistar WU rats (n = 31; mean body weight 361 +/- 24 g) were purchased from Harlan CBP (Horst, the Netherlands), and fed an HFD or an isocaloric low-fat diet (LFD) [2]. At week 8, rats fasted overnight underwent an OGTT, and post-load blood glucose levels were determined 15, 30, 60, 90 and 120 min after ingestion of 2 g glucose/kg body weight [2]. After 10 weeks on the diet, blood was collected for determination of glucose and insulin levels. Rats were then anaesthetised with an intraperitoneal injection of sodium pentobarbital, and hearts were removed for the isolation of cardiomyocytes [15].
###end p 17
###begin p 18
###xml 0 5 0 5 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Diets</bold>
Diets Experimental diets were obtained from Hope Farms (Woerden, the Netherlands; HFD, catalogue no. 4148.02; LFD, catalogue no. 4148.01). The LFD consisted of 8% by weight of total fat, 22% by weight of protein and 60% by weight of carbohydrate; the HFD contained 25% by weight of fat, 32% by weight of protein and 25% by weight of carbohydrate, as well as more palmitate (91.12 g/kg) and oleate (100.24 g/kg) compared with the LFD (29.12 and 32.08 g/kg, respectively). In the group fed the HFD, 50.4% of the ingested calories were derived from fat compared with 16.4% in the group fed the LFD.
###end p 18
###begin p 19
###xml 0 24 0 24 <bold xmlns:xlink="http://www.w3.org/1999/xlink">In vivo cardiac function</bold>
###xml 185 186 185 186 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 189 190 189 190 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 207 209 207 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR16">16</xref>
###xml 772 774 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR17">17</xref>
###xml 905 906 905 906 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 941 942 941 942 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 1099 1101 1099 1101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR18">18</xref>
###xml 128 132 <span type="species:ncbi:10116">rats</span>
In vivo cardiac function Non-invasive transthoracic echocardiograms were recorded at heart rates of 350-400 beats per minute in rats anaesthetised with 1.5% isoflurane in a mixture of N2O/O2 (1/2, vol/vol) [16] before and 8 weeks after initiation of the diet by an Aloka echo machine (ProSound SSD-4000) using a 13-MHz linear interfaced array transducer. M- and B-mode images were obtained in the parasternal long- and short-axis views of the left ventricle (LV) at mid-papillary level. At end systole (ES) and end diastole (ED), LV lumen diameter (D), LV ventricular diameter (VD) and posterior (PWT) and interventricular septum (IVSWT) wall thicknesses were determined for three cardiac cycles and averaged. The LV dimensions were used to calculate systolic parameters [17]: fractional shortening , where EDD is end diastolic diameter and ESD is end systolic diameter; end diastolic volume (EDV) = [EDD]3; end systolic volume (ESV) = [ESD]3; and ejection fraction . LV mass (LVM) was determined according to the uncorrected cube assumption: , where 1.05 is the specific gravity of the myocardium [18].
###end p 19
###begin p 20
###xml 0 32 0 32 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Plasma and tissue determinations</bold>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
Plasma and tissue determinations Blood glucose was measured from tail bleeds using a glucose analyser (HemoCue, Angelholm, Sweden). Plasma insulin was measured using ELISA (EZRMI-13K; Linco Research, St Charles, MO, USA). Myocardial triacylglycerol content was determined in ventricular lysates from a separate set of animals as described in [2].
###end p 20
###begin p 21
###xml 0 36 0 36 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Treatment of isolated cardiomyocytes</bold>
###xml 120 122 120 122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR19">19</xref>
###xml 222 223 222 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 259 261 259 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR20">20</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 420 422 420 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR21">21</xref>
###xml 749 751 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1058 1060 1045 1047 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
Treatment of isolated cardiomyocytes Cardiomyocytes were prepared using a Langendorff perfusion system as described in [15, 19]. Isolated cardiomyocytes were incubated for 30 min at room temperature with 0.5% DMSO or SSO [9]. The CD36-specific inhibitor SSO [20] was used to investigate the involvement of CD36 in basal LCFA uptake. SSO was applied at a concentration of 0.4 mmol/l, which effectively inhibits CD36 [15, 21]. Then, cells were washed and incubation was continued for 15 min at 37degreesC with continuous shaking. Thereafter, the DMSO-treated cardiomyocytes were kept for another 15 min at 37degreesC and either kept untreated (basal) or incubated with insulin or oligomycin. To achieve optimal stimulation of glucose and LCFA uptake [22], insulin and oligomycin were used at a concentration of 10 nmol/l and 30 mumol/l, respectively. At this concentration, the ATP-synthase inhibitor oligomycin induces an increase in the intracellular AMP/ATP ratio, thereby activating AMPK-mediated signalling pathways without inhibiting oxygen consumption [14].
###end p 21
###begin p 22
###xml 0 96 0 96 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Glucose uptake, palmitate uptake and oxidation, and incorporation into intracellular lipid pools</bold>
###xml 127 128 127 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3</sup>
###xml 153 155 153 155 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR15">15</xref>
###xml 250 252 250 252 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 306 308 306 308 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 310 311 310 311 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 366 368 366 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">14</sup>
###xml 479 480 479 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
Glucose uptake, palmitate uptake and oxidation, and incorporation into intracellular lipid pools Following agonist treatment, [3H]-2-deoxyglucose and [1-14C] palmitate uptake were simultaneously determined during a 3-min incubation [15]. Rates of [1-14C] palmitate oxidation (measured as the production of 14CO2) and esterification (measured as incorporation of the 14C label into intracellular phospholipids [PL], and triacylglycerol) were determined after a 20-min incubation [9].
###end p 22
###begin p 23
###xml 0 16 0 16 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Western blotting</bold>
###xml 237 238 237 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 335 336 335 336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 442 444 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 515 516 515 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
Western blotting Phosphorylation of proline-rich Akt-substrate 40 (PRAS40-Thr246) and acetyl-coenzyme A carboxylase-Ser79 (ACC-Ser79) was determined in homogenates of cardiomyocytes by western blotting using phospho-specific antibodies [9, 13]. PKB/Akt-Ser473 phosphorylation was determined in ventricular homogenates as described in [2]. Expression levels of CD36 were determined by western blotting using the monoclonal CD36 MO25 antibody [23]. Immunoblots were quantified by densitometric analysis of the films [2].
###end p 23
###begin p 24
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cardiac morphology and subcellular localisation of CD36</bold>
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 726 728 725 727 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR24">24</xref>
###xml 927 929 926 928 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR23">23</xref>
###xml 1451 1452 1443 1444 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1453 1454 1445 1446 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1111 1116 <span type="species:ncbi:10090">mouse</span>
Cardiac morphology and subcellular localisation of CD36 Cardiac ventricular tissue collected in a previous study [2] was routinely embedded in paraffin (Histowax; Leica Microsystems, Wetzlar, Germany). Sections (5 mum) were cut, and mounted on slides coated with 3-aminopropyltriethoxisilane (Menzal, Darmstadt, Germany). After deparaffinisation and rehydration, the slides were used for determination of cardiomyocyte cross-sectional area or immunohistochemical staining of CD36.Cross-sectional area was determined in randomly chosen fields in haematoxylin/eosin-stained slides using NIH image analysis software (National Institutes of Health, Bethesda, MD, USA) for 20-30 cells per heart and normalised to sarcomere length [24].For CD36 localisation, sections were rinsed extensively with Tris-buffered saline (TBS; 50 mmol/l Tris-Cl, 500 mmol/l NaCl, pH 7.6), and incubated overnight with the monoclonal CD36 MO25 antibody [23] diluted 1:2,000 in TBS containing 0.5% Triton X-100, pH 7.6 at 4degreesC. After several washes in TBS, sections were incubated for 1.5 h at room temperature with biotinylated anti-mouse IgG (Vector Laboratories, Burlingame, CA, USA), diluted 1:250 in TBS, followed by incubation for 1 h at room temperature with avidin-biotin-peroxidase (1:400; ABC Elite kit; Vector Laboratories). Tissue-bound peroxidase was visualised with the 3,3'-diaminobenzidine tetrahydrochloride (DAB) chromogen reaction (7.5 mg DAB, 5 mul 30% H2O2 in 15 ml 50 mmol/l Tris-Cl, pH 7.6) for 10 min at room temperature. Sections were then rinsed with distilled water, dehydrated in a graded series of ethanol, cleared in xylene, and coverslipped with Entellan (Merck, Darmstadt, Germany). Sections were analysed using a Leica DM-LB light microscope (Leica, Rijswijk, the Netherlands). Digital images were taken at x200 magnification using a Leica DC500 digital camera, and quantified using Quantity One software (Bio-Rad Laboratories, Veenendaal, the Netherlands).
###end p 24
###begin p 25
###xml 0 20 0 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Statistical analysis</bold>
###xml 119 120 117 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 302 303 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 329 330 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 420 421 418 419 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
Statistical analysis Unless indicated otherwise, data are expressed as means+/-SE for the indicated number of animals (n). Statistical analysis was performed in SPSS for Mac OS X version 11.0.4 (SPSS Inc., Chicago, IL, USA). Differences between the LFD and HFD groups were determined using independent t tests. The paired sample t test was used to define the effect of agonist incubations on cardiomyocyte preparations. p < 0.05 was considered as statistically significant.
###end p 25
###begin title 26
Results
###end title 26
###begin p 27
###xml 0 43 0 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HFD induces cardiac contractile dysfunction</bold>
###xml 151 152 151 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 232 233 232 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 259 260 259 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig1" ref-type="fig">1</xref>
###xml 413 414 413 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 528 529 528 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 588 589 588 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 674 675 674 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 691 692 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 802 803 802 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 855 856 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 938 939 938 939 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1022 1023 1022 1023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1038 1039 1038 1039 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1130 1137 1130 1137 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;1</label>
###xml 1137 1220 1137 1220 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28">In vivo cardiac characteristics of rats before and after 8&#160;weeks on an HFD or a LFD</p>
###xml 1137 1220 1137 1220 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28">In vivo cardiac characteristics of rats before and after 8&#160;weeks on an HFD or a LFD</p></caption>
###xml 1220 1221 1220 1221 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">&#160;</th>
###xml 1221 1226 1221 1226 <th xmlns:xlink="http://www.w3.org/1999/xlink">Start</th>
###xml 1226 1229 1226 1229 <th xmlns:xlink="http://www.w3.org/1999/xlink">LFD</th>
###xml 1229 1232 1229 1232 <th xmlns:xlink="http://www.w3.org/1999/xlink">HFD</th>
###xml 1220 1232 1220 1232 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">&#160;</th><th>Start</th><th>LFD</th><th>HFD</th></tr>
###xml 1233 1234 1233 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1232 1240 1232 1240 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;24)</th>
###xml 1241 1242 1241 1242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1240 1247 1240 1247 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;8)</th>
###xml 1248 1249 1248 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1247 1255 1247 1255 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;16)</th>
###xml 1232 1255 1232 1255 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>(<italic>n</italic>&#8201;=&#8201;24)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th><th>(<italic>n</italic>&#8201;=&#8201;16)</th></tr>
###xml 1220 1255 1220 1255 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">&#160;</th><th>Start</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;24)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th><th>(<italic>n</italic>&#8201;=&#8201;16)</th></tr></thead>
###xml 1255 1279 1255 1279 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">Physiological parameters</td>
###xml 1255 1279 1255 1279 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">Physiological parameters</td></tr>
###xml 1279 1295 1279 1295 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Body weight (g)</td>
###xml 1295 1304 1295 1302 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">295&#8201;&#177;&#8201;4</td>
###xml 1304 1314 1302 1310 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">476&#8201;&#177;&#8201;8*</td>
###xml 1314 1324 1310 1318 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">463&#8201;&#177;&#8201;8*</td>
###xml 1279 1324 1279 1318 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Body weight (g)</td><td align="center">295&#8201;&#177;&#8201;4</td><td align="center">476&#8201;&#177;&#8201;8*</td><td align="center">463&#8201;&#177;&#8201;8*</td></tr>
###xml 1324 1351 1318 1345 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Left ventricular mass (mg)</td>
###xml 1351 1361 1345 1353 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">637&#8201;&#177;&#8201;15</td>
###xml 1361 1372 1353 1362 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">890&#8201;&#177;&#8201;18*</td>
###xml 1372 1383 1362 1371 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">882&#8201;&#177;&#8201;32*</td>
###xml 1324 1383 1318 1371 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Left ventricular mass (mg)</td><td align="center">637&#8201;&#177;&#8201;15</td><td align="center">890&#8201;&#177;&#8201;18*</td><td align="center">882&#8201;&#177;&#8201;32*</td></tr>
###xml 1383 1406 1371 1394 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">LV diastolic parameters</td>
###xml 1383 1406 1371 1394 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">LV diastolic parameters</td></tr>
###xml 1406 1436 1394 1424 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Posterior wall thickness (mm)</td>
###xml 1436 1449 1424 1435 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.63&#8201;&#177;&#8201;0.03</td>
###xml 1449 1462 1435 1446 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.80&#8201;&#177;&#8201;0.07</td>
###xml 1462 1475 1446 1457 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.71&#8201;&#177;&#8201;0.05</td>
###xml 1406 1475 1394 1457 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Posterior wall thickness (mm)</td><td align="center">1.63&#8201;&#177;&#8201;0.03</td><td align="center">1.80&#8201;&#177;&#8201;0.07</td><td align="center">1.71&#8201;&#177;&#8201;0.05</td></tr>
###xml 1475 1495 1457 1477 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Lumen diameter (mm)</td>
###xml 1495 1508 1477 1488 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">6.92&#8201;&#177;&#8201;0.07</td>
###xml 1508 1522 1488 1500 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">7.55&#8201;&#177;&#8201;0.20*</td>
###xml 1522 1536 1500 1512 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">7.68&#8201;&#177;&#8201;0.10*</td>
###xml 1475 1536 1457 1512 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Lumen diameter (mm)</td><td align="center">6.92&#8201;&#177;&#8201;0.07</td><td align="center">7.55&#8201;&#177;&#8201;0.20*</td><td align="center">7.68&#8201;&#177;&#8201;0.10*</td></tr>
###xml 1536 1580 1512 1556 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Interventricular septum wall thickness (mm)</td>
###xml 1580 1593 1556 1567 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.37&#8201;&#177;&#8201;0.03</td>
###xml 1593 1607 1567 1579 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.67&#8201;&#177;&#8201;0.08*</td>
###xml 1607 1621 1579 1591 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.54&#8201;&#177;&#8201;0.04*</td>
###xml 1536 1621 1512 1591 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">1.37&#8201;&#177;&#8201;0.03</td><td align="center">1.67&#8201;&#177;&#8201;0.08*</td><td align="center">1.54&#8201;&#177;&#8201;0.04*</td></tr>
###xml 1621 1647 1591 1617 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Ventricular diameter (mm)</td>
###xml 1647 1660 1617 1628 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">9.80&#8201;&#177;&#8201;0.06</td>
###xml 1660 1675 1628 1641 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">10.86&#8201;&#177;&#8201;0.13*</td>
###xml 1675 1690 1641 1654 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">10.89&#8201;&#177;&#8201;0.12*</td>
###xml 1621 1690 1591 1654 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Ventricular diameter (mm)</td><td align="center">9.80&#8201;&#177;&#8201;0.06</td><td align="center">10.86&#8201;&#177;&#8201;0.13*</td><td align="center">10.89&#8201;&#177;&#8201;0.12*</td></tr>
###xml 1690 1712 1654 1676 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="4">LV systolic parameters</td>
###xml 1690 1712 1654 1676 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="4">LV systolic parameters</td></tr>
###xml 1712 1742 1676 1706 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Posterior wall thickness (mm)</td>
###xml 1742 1755 1706 1717 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">2.93&#8201;&#177;&#8201;0.06</td>
###xml 1755 1769 1717 1729 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.45&#8201;&#177;&#8201;0.12*</td>
###xml 1769 1784 1729 1742 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.00&#8201;&#177;&#8201;0.08**</td>
###xml 1712 1784 1676 1742 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Posterior wall thickness (mm)</td><td align="center">2.93&#8201;&#177;&#8201;0.06</td><td align="center">3.45&#8201;&#177;&#8201;0.12*</td><td align="center">3.00&#8201;&#177;&#8201;0.08**</td></tr>
###xml 1784 1804 1742 1762 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Lumen diameter (mm)</td>
###xml 1804 1817 1762 1773 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.41&#8201;&#177;&#8201;0.10</td>
###xml 1817 1830 1773 1784 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.32&#8201;&#177;&#8201;0.25</td>
###xml 1844 1845 1796 1797 <sup xmlns:xlink="http://www.w3.org/1999/xlink">,</sup>
###xml 1830 1847 1784 1799 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">4.07&#8201;&#177;&#8201;0.12*<sup>,</sup>**</td>
###xml 1784 1847 1742 1799 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Lumen diameter (mm)</td><td align="center">3.41&#8201;&#177;&#8201;0.10</td><td align="center">3.32&#8201;&#177;&#8201;0.25</td><td align="center">4.07&#8201;&#177;&#8201;0.12*<sup>,</sup>**</td></tr>
###xml 1847 1891 1799 1843 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Interventricular septum wall thickness (mm)</td>
###xml 1891 1904 1843 1854 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">2.51&#8201;&#177;&#8201;0.05</td>
###xml 1904 1918 1854 1866 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">2.85&#8201;&#177;&#8201;0.09*</td>
###xml 1918 1931 1866 1877 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">2.67&#8201;&#177;&#8201;0.06</td>
###xml 1847 1931 1799 1877 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">2.51&#8201;&#177;&#8201;0.05</td><td align="center">2.85&#8201;&#177;&#8201;0.09*</td><td align="center">2.67&#8201;&#177;&#8201;0.06</td></tr>
###xml 1931 1957 1877 1903 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Ventricular diameter (mm)</td>
###xml 1957 1970 1903 1914 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">8.81&#8201;&#177;&#8201;0.07</td>
###xml 1970 1984 1914 1926 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">9.82&#8201;&#177;&#8201;0.12*</td>
###xml 1984 1998 1926 1938 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">9.81&#8201;&#177;&#8201;0.10*</td>
###xml 1931 1998 1877 1938 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Ventricular diameter (mm)</td><td align="center">8.81&#8201;&#177;&#8201;0.07</td><td align="center">9.82&#8201;&#177;&#8201;0.12*</td><td align="center">9.81&#8201;&#177;&#8201;0.10*</td></tr>
###xml 1998 2024 1938 1964 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Fractional shortening (%)</td>
###xml 2024 2036 1964 1974 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">50.8&#8201;&#177;&#8201;1.3</td>
###xml 2036 2049 1974 1985 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">56.3&#8201;&#177;&#8201;2.4*</td>
###xml 2062 2063 1996 1997 <sup xmlns:xlink="http://www.w3.org/1999/xlink">,</sup>
###xml 2049 2065 1985 1999 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">47.1&#8201;&#177;&#8201;1.7*<sup>,</sup>**</td>
###xml 1998 2065 1938 1999 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Fractional shortening (%)</td><td align="center">50.8&#8201;&#177;&#8201;1.3</td><td align="center">56.3&#8201;&#177;&#8201;2.4*</td><td align="center">47.1&#8201;&#177;&#8201;1.7*<sup>,</sup>**</td></tr>
###xml 2065 2087 1999 2021 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Ejection fraction (%)</td>
###xml 2087 2099 2021 2031 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">87.5&#8201;&#177;&#8201;1.0</td>
###xml 2099 2111 2031 2041 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">91.1&#8201;&#177;&#8201;1.4</td>
###xml 2124 2125 2052 2053 <sup xmlns:xlink="http://www.w3.org/1999/xlink">,</sup>
###xml 2111 2127 2041 2055 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">84.9&#8201;&#177;&#8201;1.0*<sup>,</sup>**</td>
###xml 2065 2127 1999 2055 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Ejection fraction (%)</td><td align="center">87.5&#8201;&#177;&#8201;1.0</td><td align="center">91.1&#8201;&#177;&#8201;1.4</td><td align="center">84.9&#8201;&#177;&#8201;1.0*<sup>,</sup>**</td></tr>
###xml 1255 2127 1255 2055 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="4">Physiological parameters</td></tr><tr><td>&#160;Body weight (g)</td><td align="center">295&#8201;&#177;&#8201;4</td><td align="center">476&#8201;&#177;&#8201;8*</td><td align="center">463&#8201;&#177;&#8201;8*</td></tr><tr><td>&#160;Left ventricular mass (mg)</td><td align="center">637&#8201;&#177;&#8201;15</td><td align="center">890&#8201;&#177;&#8201;18*</td><td align="center">882&#8201;&#177;&#8201;32*</td></tr><tr><td colspan="4">LV diastolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">1.63&#8201;&#177;&#8201;0.03</td><td align="center">1.80&#8201;&#177;&#8201;0.07</td><td align="center">1.71&#8201;&#177;&#8201;0.05</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">6.92&#8201;&#177;&#8201;0.07</td><td align="center">7.55&#8201;&#177;&#8201;0.20*</td><td align="center">7.68&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">1.37&#8201;&#177;&#8201;0.03</td><td align="center">1.67&#8201;&#177;&#8201;0.08*</td><td align="center">1.54&#8201;&#177;&#8201;0.04*</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">9.80&#8201;&#177;&#8201;0.06</td><td align="center">10.86&#8201;&#177;&#8201;0.13*</td><td align="center">10.89&#8201;&#177;&#8201;0.12*</td></tr><tr><td colspan="4">LV systolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">2.93&#8201;&#177;&#8201;0.06</td><td align="center">3.45&#8201;&#177;&#8201;0.12*</td><td align="center">3.00&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">3.41&#8201;&#177;&#8201;0.10</td><td align="center">3.32&#8201;&#177;&#8201;0.25</td><td align="center">4.07&#8201;&#177;&#8201;0.12*<sup>,</sup>**</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">2.51&#8201;&#177;&#8201;0.05</td><td align="center">2.85&#8201;&#177;&#8201;0.09*</td><td align="center">2.67&#8201;&#177;&#8201;0.06</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">8.81&#8201;&#177;&#8201;0.07</td><td align="center">9.82&#8201;&#177;&#8201;0.12*</td><td align="center">9.81&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Fractional shortening (%)</td><td align="center">50.8&#8201;&#177;&#8201;1.3</td><td align="center">56.3&#8201;&#177;&#8201;2.4*</td><td align="center">47.1&#8201;&#177;&#8201;1.7*<sup>,</sup>**</td></tr><tr><td>&#160;Ejection fraction (%)</td><td align="center">87.5&#8201;&#177;&#8201;1.0</td><td align="center">91.1&#8201;&#177;&#8201;1.4</td><td align="center">84.9&#8201;&#177;&#8201;1.0*<sup>,</sup>**</td></tr></tbody>
###xml 1220 2127 1220 2055 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>Start</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;24)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th><th>(<italic>n</italic>&#8201;=&#8201;16)</th></tr></thead><tbody><tr><td colspan="4">Physiological parameters</td></tr><tr><td>&#160;Body weight (g)</td><td align="center">295&#8201;&#177;&#8201;4</td><td align="center">476&#8201;&#177;&#8201;8*</td><td align="center">463&#8201;&#177;&#8201;8*</td></tr><tr><td>&#160;Left ventricular mass (mg)</td><td align="center">637&#8201;&#177;&#8201;15</td><td align="center">890&#8201;&#177;&#8201;18*</td><td align="center">882&#8201;&#177;&#8201;32*</td></tr><tr><td colspan="4">LV diastolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">1.63&#8201;&#177;&#8201;0.03</td><td align="center">1.80&#8201;&#177;&#8201;0.07</td><td align="center">1.71&#8201;&#177;&#8201;0.05</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">6.92&#8201;&#177;&#8201;0.07</td><td align="center">7.55&#8201;&#177;&#8201;0.20*</td><td align="center">7.68&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">1.37&#8201;&#177;&#8201;0.03</td><td align="center">1.67&#8201;&#177;&#8201;0.08*</td><td align="center">1.54&#8201;&#177;&#8201;0.04*</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">9.80&#8201;&#177;&#8201;0.06</td><td align="center">10.86&#8201;&#177;&#8201;0.13*</td><td align="center">10.89&#8201;&#177;&#8201;0.12*</td></tr><tr><td colspan="4">LV systolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">2.93&#8201;&#177;&#8201;0.06</td><td align="center">3.45&#8201;&#177;&#8201;0.12*</td><td align="center">3.00&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">3.41&#8201;&#177;&#8201;0.10</td><td align="center">3.32&#8201;&#177;&#8201;0.25</td><td align="center">4.07&#8201;&#177;&#8201;0.12*<sup>,</sup>**</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">2.51&#8201;&#177;&#8201;0.05</td><td align="center">2.85&#8201;&#177;&#8201;0.09*</td><td align="center">2.67&#8201;&#177;&#8201;0.06</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">8.81&#8201;&#177;&#8201;0.07</td><td align="center">9.82&#8201;&#177;&#8201;0.12*</td><td align="center">9.81&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Fractional shortening (%)</td><td align="center">50.8&#8201;&#177;&#8201;1.3</td><td align="center">56.3&#8201;&#177;&#8201;2.4*</td><td align="center">47.1&#8201;&#177;&#8201;1.7*<sup>,</sup>**</td></tr><tr><td>&#160;Ejection fraction (%)</td><td align="center">87.5&#8201;&#177;&#8201;1.0</td><td align="center">91.1&#8201;&#177;&#8201;1.4</td><td align="center">84.9&#8201;&#177;&#8201;1.0*<sup>,</sup>**</td></tr></tbody></table>
###xml 2127 2146 2055 2072 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="29">Data are means&#177;SE</p>
###xml 2147 2148 2073 2074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2146 2164 2072 2090 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="30">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs start</p>
###xml 2166 2167 2092 2093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2164 2181 2090 2107 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31">**<italic>p</italic>&#8201;&lt;&#8201;0.01 vs LFD</p>
###xml 2127 2181 2055 2107 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="29">Data are means&#177;SE</p><p textid="30">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs start</p><p textid="31">**<italic>p</italic>&#8201;&lt;&#8201;0.01 vs LFD</p></table-wrap-foot>
###xml 1130 2181 1130 2107 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab1"><label>Table&#160;1</label><caption><p textid="28">In vivo cardiac characteristics of rats before and after 8&#160;weeks on an HFD or a LFD</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>Start</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;24)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th><th>(<italic>n</italic>&#8201;=&#8201;16)</th></tr></thead><tbody><tr><td colspan="4">Physiological parameters</td></tr><tr><td>&#160;Body weight (g)</td><td align="center">295&#8201;&#177;&#8201;4</td><td align="center">476&#8201;&#177;&#8201;8*</td><td align="center">463&#8201;&#177;&#8201;8*</td></tr><tr><td>&#160;Left ventricular mass (mg)</td><td align="center">637&#8201;&#177;&#8201;15</td><td align="center">890&#8201;&#177;&#8201;18*</td><td align="center">882&#8201;&#177;&#8201;32*</td></tr><tr><td colspan="4">LV diastolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">1.63&#8201;&#177;&#8201;0.03</td><td align="center">1.80&#8201;&#177;&#8201;0.07</td><td align="center">1.71&#8201;&#177;&#8201;0.05</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">6.92&#8201;&#177;&#8201;0.07</td><td align="center">7.55&#8201;&#177;&#8201;0.20*</td><td align="center">7.68&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">1.37&#8201;&#177;&#8201;0.03</td><td align="center">1.67&#8201;&#177;&#8201;0.08*</td><td align="center">1.54&#8201;&#177;&#8201;0.04*</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">9.80&#8201;&#177;&#8201;0.06</td><td align="center">10.86&#8201;&#177;&#8201;0.13*</td><td align="center">10.89&#8201;&#177;&#8201;0.12*</td></tr><tr><td colspan="4">LV systolic parameters</td></tr><tr><td>&#160;Posterior wall thickness (mm)</td><td align="center">2.93&#8201;&#177;&#8201;0.06</td><td align="center">3.45&#8201;&#177;&#8201;0.12*</td><td align="center">3.00&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Lumen diameter (mm)</td><td align="center">3.41&#8201;&#177;&#8201;0.10</td><td align="center">3.32&#8201;&#177;&#8201;0.25</td><td align="center">4.07&#8201;&#177;&#8201;0.12*<sup>,</sup>**</td></tr><tr><td>&#160;Interventricular septum wall thickness (mm)</td><td align="center">2.51&#8201;&#177;&#8201;0.05</td><td align="center">2.85&#8201;&#177;&#8201;0.09*</td><td align="center">2.67&#8201;&#177;&#8201;0.06</td></tr><tr><td>&#160;Ventricular diameter (mm)</td><td align="center">8.81&#8201;&#177;&#8201;0.07</td><td align="center">9.82&#8201;&#177;&#8201;0.12*</td><td align="center">9.81&#8201;&#177;&#8201;0.10*</td></tr><tr><td>&#160;Fractional shortening (%)</td><td align="center">50.8&#8201;&#177;&#8201;1.3</td><td align="center">56.3&#8201;&#177;&#8201;2.4*</td><td align="center">47.1&#8201;&#177;&#8201;1.7*<sup>,</sup>**</td></tr><tr><td>&#160;Ejection fraction (%)</td><td align="center">87.5&#8201;&#177;&#8201;1.0</td><td align="center">91.1&#8201;&#177;&#8201;1.4</td><td align="center">84.9&#8201;&#177;&#8201;1.0*<sup>,</sup>**</td></tr></tbody></table><table-wrap-foot><p textid="29">Data are means&#177;SE</p><p textid="30">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs start</p><p textid="31">**<italic>p</italic>&#8201;&lt;&#8201;0.01 vs LFD</p></table-wrap-foot></table-wrap>
###xml 2181 2187 2107 2113 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;1</label>
###xml 2187 2188 2113 2114 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 2258 2272 2184 2198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circles</italic>
###xml 2274 2275 2200 2201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2295 2307 2221 2233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 2309 2310 2235 2236 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2338 2339 2262 2263 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 2187 2533 2113 2457 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="32"><bold>a</bold> Blood glucose levels after an oral glucose load in rats fed the HFD (<italic>closed circles</italic>; <italic>n</italic>&#8201;=&#8201;16) and the LFD (<italic>open circles</italic>; <italic>n</italic>&#8201;=&#8201;8). Data are means&#177;SE. <bold>b</bold> Representative echocardiographic M-mode images from at least three cardiac contractile cycles at the start of the diet intervention and 8&#160;weeks after initiation of the LFD and HFD, respectively</p>
###xml 2187 2533 2113 2457 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="32"><bold>a</bold> Blood glucose levels after an oral glucose load in rats fed the HFD (<italic>closed circles</italic>; <italic>n</italic>&#8201;=&#8201;16) and the LFD (<italic>open circles</italic>; <italic>n</italic>&#8201;=&#8201;8). Data are means&#177;SE. <bold>b</bold> Representative echocardiographic M-mode images from at least three cardiac contractile cycles at the start of the diet intervention and 8&#160;weeks after initiation of the LFD and HFD, respectively</p></caption>
###xml 2533 2533 2457 2457 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig1_HTML" id="MO1"/>
###xml 2181 2533 2107 2457 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig1"><label>Fig.&#160;1</label><caption><p textid="32"><bold>a</bold> Blood glucose levels after an oral glucose load in rats fed the HFD (<italic>closed circles</italic>; <italic>n</italic>&#8201;=&#8201;16) and the LFD (<italic>open circles</italic>; <italic>n</italic>&#8201;=&#8201;8). Data are means&#177;SE. <bold>b</bold> Representative echocardiographic M-mode images from at least three cardiac contractile cycles at the start of the diet intervention and 8&#160;weeks after initiation of the LFD and HFD, respectively</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig1_HTML" id="MO1"/></fig>
###xml 52 56 <span type="species:ncbi:10116">rats</span>
###xml 226 230 <span type="species:ncbi:10116">rats</span>
###xml 796 800 <span type="species:ncbi:10116">rats</span>
###xml 1124 1128 <span type="species:ncbi:10116">rats</span>
###xml 1172 1176 <span type="species:ncbi:10116">rats</span>
###xml 2240 2244 <span type="species:ncbi:10116">rats</span>
HFD induces cardiac contractile dysfunction Feeding rats isocaloric LFD or HFD diets for 8 weeks induced similar weight gains in the two groups (Table 1), but mild glucose intolerance, as determined by an oGTT, in HFD- vs LFD-rats (p < 0.05; Fig. 1a). Figure 1b shows the LV dimensions at the start and 8 weeks after initiation of the diet interventions. Baseline parameters were similar in the two groups (Table 1). After 8 weeks on the diet, LVM, ED-VD, EDD and ED-IVSWT showed comparable increases in LFD and HFD hearts (all p < 0.05), whereas ED-PWT was unaffected by the diet (Table 1). In the ES phase, both ES-PWT and ES-IVSWT were increased in LFD hearts only (both p < 0.005; Table 1). ES-VD was similarly affected by LFD and HFD feeding. ESD was increased in LV from HFD-fed vs LFD-fed rats (p < 0.01; Table 1). FS% was increased in LFD hearts (p < 0.05), and decreased in HFD hearts during the course of the diet intervention (p < 0.02; Table 1). Accordingly, EF% was decreased in HFD compared with LFD hearts (p < 0.05; Table 1). Collectively, these data show that HFD induced cardiac contractile dysfunction in rats. Table 1In vivo cardiac characteristics of rats before and after 8 weeks on an HFD or a LFD StartLFDHFD(n = 24)(n = 8)(n = 16)Physiological parameters Body weight (g)295 +/- 4476 +/- 8*463 +/- 8* Left ventricular mass (mg)637 +/- 15890 +/- 18*882 +/- 32*LV diastolic parameters Posterior wall thickness (mm)1.63 +/- 0.031.80 +/- 0.071.71 +/- 0.05 Lumen diameter (mm)6.92 +/- 0.077.55 +/- 0.20*7.68 +/- 0.10* Interventricular septum wall thickness (mm)1.37 +/- 0.031.67 +/- 0.08*1.54 +/- 0.04* Ventricular diameter (mm)9.80 +/- 0.0610.86 +/- 0.13*10.89 +/- 0.12*LV systolic parameters Posterior wall thickness (mm)2.93 +/- 0.063.45 +/- 0.12*3.00 +/- 0.08** Lumen diameter (mm)3.41 +/- 0.103.32 +/- 0.254.07 +/- 0.12*,** Interventricular septum wall thickness (mm)2.51 +/- 0.052.85 +/- 0.09*2.67 +/- 0.06 Ventricular diameter (mm)8.81 +/- 0.079.82 +/- 0.12*9.81 +/- 0.10* Fractional shortening (%)50.8 +/- 1.356.3 +/- 2.4*47.1 +/- 1.7*,** Ejection fraction (%)87.5 +/- 1.091.1 +/- 1.484.9 +/- 1.0*,**Data are means+/-SE*p < 0.05 vs start**p < 0.01 vs LFDFig. 1a Blood glucose levels after an oral glucose load in rats fed the HFD (closed circles; n = 16) and the LFD (open circles; n = 8). Data are means+/-SE. b Representative echocardiographic M-mode images from at least three cardiac contractile cycles at the start of the diet intervention and 8 weeks after initiation of the LFD and HFD, respectively
###end p 27
###begin p 28
###xml 35 39 <span type="species:ncbi:10116">rats</span>
In vivo cardiac characteristics of rats before and after 8 weeks on an HFD or a LFD
###end p 28
###begin p 29
Data are means+/-SE
###end p 29
###begin p 30
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
*p < 0.05 vs start
###end p 30
###begin p 31
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
**p < 0.01 vs LFD
###end p 31
###begin p 32
###xml 0 1 0 1 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 71 85 71 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">closed circles</italic>
###xml 87 88 87 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 108 120 108 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open circles</italic>
###xml 122 123 122 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 151 152 149 150 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 53 57 <span type="species:ncbi:10116">rats</span>
a Blood glucose levels after an oral glucose load in rats fed the HFD (closed circles; n = 16) and the LFD (open circles; n = 8). Data are means+/-SE. b Representative echocardiographic M-mode images from at least three cardiac contractile cycles at the start of the diet intervention and 8 weeks after initiation of the LFD and HFD, respectively
###end p 32
###begin p 33
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Insulin action, but not AMPK signalling, is impaired in HFD cardiomyocytes</bold>
###xml 509 510 509 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 526 527 526 527 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab2" ref-type="table">2</xref>
###xml 587 588 587 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 632 633 632 633 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 643 650 643 650 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;2</label>
###xml 650 715 650 715 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="34">Characteristics of rats after 10&#160;weeks on a high- or low-fat diet</p>
###xml 650 715 650 715 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="34">Characteristics of rats after 10&#160;weeks on a high- or low-fat diet</p></caption>
###xml 715 716 715 716 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">&#160;</th>
###xml 716 719 716 719 <th xmlns:xlink="http://www.w3.org/1999/xlink">LFD</th>
###xml 719 722 719 722 <th xmlns:xlink="http://www.w3.org/1999/xlink">HFD</th>
###xml 715 722 715 722 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr>
###xml 723 724 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 722 730 722 730 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;14)</th>
###xml 731 732 731 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 730 738 730 738 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;17)</th>
###xml 722 738 722 738 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>(<italic>n</italic>&#8201;=&#8201;14)</th><th>(<italic>n</italic>&#8201;=&#8201;17)</th></tr>
###xml 715 738 715 738 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;14)</th><th>(<italic>n</italic>&#8201;=&#8201;17)</th></tr></thead>
###xml 738 754 738 754 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Body composition</td>
###xml 738 754 738 754 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Body composition</td></tr>
###xml 754 781 754 781 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Body weight at killing (g)</td>
###xml 781 790 781 788 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">465&#8201;&#177;&#8201;5</td>
###xml 790 800 788 796 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">472&#8201;&#177;&#8201;10</td>
###xml 754 800 754 796 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Body weight at killing (g)</td><td align="center">465&#8201;&#177;&#8201;5</td><td align="center">472&#8201;&#177;&#8201;10</td></tr>
###xml 800 829 796 825 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Heart weight (% body weight)</td>
###xml 829 844 825 838 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">0.445&#8201;&#177;&#8201;0.007</td>
###xml 844 859 838 851 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">0.431&#8201;&#177;&#8201;0.012</td>
###xml 800 859 796 851 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Heart weight (% body weight)</td><td align="center">0.445&#8201;&#177;&#8201;0.007</td><td align="center">0.431&#8201;&#177;&#8201;0.012</td></tr>
###xml 859 888 851 880 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Liver weight (% body weight)</td>
###xml 888 901 880 891 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.10&#8201;&#177;&#8201;0.07</td>
###xml 901 914 891 902 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">3.02&#8201;&#177;&#8201;0.08</td>
###xml 859 914 851 902 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Liver weight (% body weight)</td><td align="center">3.10&#8201;&#177;&#8201;0.07</td><td align="center">3.02&#8201;&#177;&#8201;0.08</td></tr>
###xml 914 955 902 943 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Perirenal fat pad weight (% body weight)</td>
###xml 955 968 943 954 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">1.63&#8201;&#177;&#8201;0.08</td>
###xml 968 982 954 966 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">2.43&#8201;&#177;&#8201;0.14*</td>
###xml 914 982 902 966 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Perirenal fat pad weight (% body weight)</td><td align="center">1.63&#8201;&#177;&#8201;0.08</td><td align="center">2.43&#8201;&#177;&#8201;0.14*</td></tr>
###xml 982 1004 966 988 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Plasma characteristics</td>
###xml 982 1004 966 988 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Plasma characteristics</td></tr>
###xml 1004 1027 988 1011 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Blood glucose (mmol/l)</td>
###xml 1027 1040 1011 1022 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">5.50&#8201;&#177;&#8201;0.08</td>
###xml 1040 1055 1022 1035 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">5.78&#8201;&#177;&#8201;0.08**</td>
###xml 1004 1055 988 1035 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Blood glucose (mmol/l)</td><td align="center">5.50&#8201;&#177;&#8201;0.08</td><td align="center">5.78&#8201;&#177;&#8201;0.08**</td></tr>
###xml 1055 1079 1035 1059 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Plasma insulin (pmol/l)</td>
###xml 1079 1089 1059 1067 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">269&#8201;&#177;&#8201;18</td>
###xml 1089 1102 1067 1078 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">216&#8201;&#177;&#8201;16***</td>
###xml 1055 1102 1035 1078 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Plasma insulin (pmol/l)</td><td align="center">269&#8201;&#177;&#8201;18</td><td align="center">216&#8201;&#177;&#8201;16***</td></tr>
###xml 738 1102 738 1078 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="3">Body composition</td></tr><tr><td>&#160;Body weight at killing (g)</td><td align="center">465&#8201;&#177;&#8201;5</td><td align="center">472&#8201;&#177;&#8201;10</td></tr><tr><td>&#160;Heart weight (% body weight)</td><td align="center">0.445&#8201;&#177;&#8201;0.007</td><td align="center">0.431&#8201;&#177;&#8201;0.012</td></tr><tr><td>&#160;Liver weight (% body weight)</td><td align="center">3.10&#8201;&#177;&#8201;0.07</td><td align="center">3.02&#8201;&#177;&#8201;0.08</td></tr><tr><td>&#160;Perirenal fat pad weight (% body weight)</td><td align="center">1.63&#8201;&#177;&#8201;0.08</td><td align="center">2.43&#8201;&#177;&#8201;0.14*</td></tr><tr><td colspan="3">Plasma characteristics</td></tr><tr><td>&#160;Blood glucose (mmol/l)</td><td align="center">5.50&#8201;&#177;&#8201;0.08</td><td align="center">5.78&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Plasma insulin (pmol/l)</td><td align="center">269&#8201;&#177;&#8201;18</td><td align="center">216&#8201;&#177;&#8201;16***</td></tr></tbody>
###xml 715 1102 715 1078 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;14)</th><th>(<italic>n</italic>&#8201;=&#8201;17)</th></tr></thead><tbody><tr><td colspan="3">Body composition</td></tr><tr><td>&#160;Body weight at killing (g)</td><td align="center">465&#8201;&#177;&#8201;5</td><td align="center">472&#8201;&#177;&#8201;10</td></tr><tr><td>&#160;Heart weight (% body weight)</td><td align="center">0.445&#8201;&#177;&#8201;0.007</td><td align="center">0.431&#8201;&#177;&#8201;0.012</td></tr><tr><td>&#160;Liver weight (% body weight)</td><td align="center">3.10&#8201;&#177;&#8201;0.07</td><td align="center">3.02&#8201;&#177;&#8201;0.08</td></tr><tr><td>&#160;Perirenal fat pad weight (% body weight)</td><td align="center">1.63&#8201;&#177;&#8201;0.08</td><td align="center">2.43&#8201;&#177;&#8201;0.14*</td></tr><tr><td colspan="3">Plasma characteristics</td></tr><tr><td>&#160;Blood glucose (mmol/l)</td><td align="center">5.50&#8201;&#177;&#8201;0.08</td><td align="center">5.78&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Plasma insulin (pmol/l)</td><td align="center">269&#8201;&#177;&#8201;18</td><td align="center">216&#8201;&#177;&#8201;16***</td></tr></tbody></table>
###xml 1102 1121 1078 1095 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="35">Data are means&#177;SE</p>
###xml 1122 1123 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1121 1138 1095 1112 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="36">*<italic>p</italic>&#8201;&lt;&#8201;0.001 vs LFD</p>
###xml 1140 1141 1114 1115 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1138 1155 1112 1129 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="37">**<italic>p</italic>&#8201;&lt;&#8201;0.02 vs LFD</p>
###xml 1158 1159 1132 1133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1155 1173 1129 1147 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="38">***<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p>
###xml 1102 1173 1078 1147 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="35">Data are means&#177;SE</p><p textid="36">*<italic>p</italic>&#8201;&lt;&#8201;0.001 vs LFD</p><p textid="37">**<italic>p</italic>&#8201;&lt;&#8201;0.02 vs LFD</p><p textid="38">***<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p></table-wrap-foot>
###xml 643 1173 643 1147 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab2"><label>Table&#160;2</label><caption><p textid="34">Characteristics of rats after 10&#160;weeks on a high- or low-fat diet</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;14)</th><th>(<italic>n</italic>&#8201;=&#8201;17)</th></tr></thead><tbody><tr><td colspan="3">Body composition</td></tr><tr><td>&#160;Body weight at killing (g)</td><td align="center">465&#8201;&#177;&#8201;5</td><td align="center">472&#8201;&#177;&#8201;10</td></tr><tr><td>&#160;Heart weight (% body weight)</td><td align="center">0.445&#8201;&#177;&#8201;0.007</td><td align="center">0.431&#8201;&#177;&#8201;0.012</td></tr><tr><td>&#160;Liver weight (% body weight)</td><td align="center">3.10&#8201;&#177;&#8201;0.07</td><td align="center">3.02&#8201;&#177;&#8201;0.08</td></tr><tr><td>&#160;Perirenal fat pad weight (% body weight)</td><td align="center">1.63&#8201;&#177;&#8201;0.08</td><td align="center">2.43&#8201;&#177;&#8201;0.14*</td></tr><tr><td colspan="3">Plasma characteristics</td></tr><tr><td>&#160;Blood glucose (mmol/l)</td><td align="center">5.50&#8201;&#177;&#8201;0.08</td><td align="center">5.78&#8201;&#177;&#8201;0.08**</td></tr><tr><td>&#160;Plasma insulin (pmol/l)</td><td align="center">269&#8201;&#177;&#8201;18</td><td align="center">216&#8201;&#177;&#8201;16***</td></tr></tbody></table><table-wrap-foot><p textid="35">Data are means&#177;SE</p><p textid="36">*<italic>p</italic>&#8201;&lt;&#8201;0.001 vs LFD</p><p textid="37">**<italic>p</italic>&#8201;&lt;&#8201;0.02 vs LFD</p><p textid="38">***<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p></table-wrap-foot></table-wrap>
###xml 1257 1259 1227 1229 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;1</sup>
###xml 1277 1279 1247 1249 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-1</sup>
###xml 1317 1318 1287 1288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1333 1334 1303 1304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig2" ref-type="fig">2</xref>
###xml 1450 1451 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1470 1471 1440 1441 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1704 1705 1674 1675 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1724 1730 1694 1700 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;2</label>
###xml 1802 1811 1772 1781 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 1826 1837 1796 1807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 1881 1886 1851 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 1898 1901 1868 1871 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 1918 1921 1888 1891 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 2024 2025 1992 1993 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 2032 2033 2000 2001 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2059 2060 2027 2028 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1730 2080 1700 2048 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39">Rates of 2-deoxyglucose uptake in cardiomyocytes from rats fed the LFD (<italic>open bars</italic>) and the HFD (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>) before measurement of 2-deoxyglucose uptake. Data are expressed as wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.02, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.02, diet effect</p>
###xml 1730 2080 1700 2048 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39">Rates of 2-deoxyglucose uptake in cardiomyocytes from rats fed the LFD (<italic>open bars</italic>) and the HFD (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>) before measurement of 2-deoxyglucose uptake. Data are expressed as wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.02, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.02, diet effect</p></caption>
###xml 2080 2080 2048 2048 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig2_HTML" id="MO2"/>
###xml 1724 2080 1694 2048 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig2"><label>Fig.&#160;2</label><caption><p textid="39">Rates of 2-deoxyglucose uptake in cardiomyocytes from rats fed the LFD (<italic>open bars</italic>) and the HFD (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>) before measurement of 2-deoxyglucose uptake. Data are expressed as wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.02, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.02, diet effect</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig2_HTML" id="MO2"/></fig>
###xml 2607 2609 2575 2577 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 2611 2613 2579 2581 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 2905 2906 2869 2870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2920 2921 2884 2885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 3000 3001 2964 2965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3038 3039 3002 3003 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3155 3161 3119 3125 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;3</label>
###xml 3174 3175 3138 3139 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 3177 3178 3141 3142 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 3217 3218 3181 3182 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 3235 3236 3199 3200 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 3327 3332 3291 3296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 3344 3347 3308 3311 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 3364 3367 3328 3331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 3391 3392 3353 3354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 3399 3400 3361 3362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3426 3427 3388 3389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 3161 3447 3125 3409 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="40">Immunoblots (<bold>a</bold>, <bold>c</bold>) and quantification of PRAS40-Thr246 (<bold>b</bold>) and ACC-Ser79 (<bold>d</bold>) phosphorylation after incubation of cardiomyocytes from LFD- and HFD-fed rats with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>). Data are means&#177;SE; <italic>n</italic>&#8201;=&#8201;5. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p>
###xml 3161 3447 3125 3409 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="40">Immunoblots (<bold>a</bold>, <bold>c</bold>) and quantification of PRAS40-Thr246 (<bold>b</bold>) and ACC-Ser79 (<bold>d</bold>) phosphorylation after incubation of cardiomyocytes from LFD- and HFD-fed rats with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>). Data are means&#177;SE; <italic>n</italic>&#8201;=&#8201;5. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p></caption>
###xml 3447 3447 3409 3409 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig3_HTML" id="MO3"/>
###xml 3155 3447 3119 3409 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig3"><label>Fig.&#160;3</label><caption><p textid="40">Immunoblots (<bold>a</bold>, <bold>c</bold>) and quantification of PRAS40-Thr246 (<bold>b</bold>) and ACC-Ser79 (<bold>d</bold>) phosphorylation after incubation of cardiomyocytes from LFD- and HFD-fed rats with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>) or oligomycin (<italic>Oli</italic>). Data are means&#177;SE; <italic>n</italic>&#8201;=&#8201;5. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig3_HTML" id="MO3"/></fig>
###xml 3521 3523 3483 3485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR25">25</xref>
###xml 3607 3608 3569 3570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig3" ref-type="fig">3</xref>
###xml 3823 3824 3785 3786 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 268 272 <span type="species:ncbi:10116">rats</span>
###xml 425 429 <span type="species:ncbi:10116">rats</span>
###xml 503 507 <span type="species:ncbi:10116">rats</span>
###xml 669 673 <span type="species:ncbi:10116">rats</span>
###xml 1784 1788 <span type="species:ncbi:10116">rats</span>
###xml 2635 2641 <span type="species:ncbi:9913">bovine</span>
###xml 3311 3315 <span type="species:ncbi:10116">rats</span>
Insulin action, but not AMPK signalling, is impaired in HFD cardiomyocytes We used cardiomyocytes to unravel the diet-induced molecular alterations in energy substrate uptake and intracellular signalling pathways. Cardiomyocytes were isolated from a separate group of rats, fed either the LFD or the HFD under identical experimental conditions. At killing, body, heart and liver weights were similar between LFD- and HFD-fed rats, whereas perirenal fat pad weight was 50% higher in HFD- than in LFD-fed rats (p < 0.001; Table 2). Furthermore, HFD feeding increased blood glucose levels (p < 0.02) and lowered plasma insulin levels (p < 0.05). Table 2Characteristics of rats after 10 weeks on a high- or low-fat diet LFDHFD(n = 14)(n = 17)Body composition Body weight at killing (g)465 +/- 5472 +/- 10 Heart weight (% body weight)0.445 +/- 0.0070.431 +/- 0.012 Liver weight (% body weight)3.10 +/- 0.073.02 +/- 0.08 Perirenal fat pad weight (% body weight)1.63 +/- 0.082.43 +/- 0.14*Plasma characteristics Blood glucose (mmol/l)5.50 +/- 0.085.78 +/- 0.08** Plasma insulin (pmol/l)269 +/- 18216 +/- 16***Data are means+/-SE*p < 0.001 vs LFD**p < 0.02 vs LFD***p < 0.05 vs LFDBasal 2-deoxyglucose glucose uptake rates were 7.3 +/- 0.8 and 11.0 +/- 1.6 nmol min-1 [g wet cell mass]-1C in LFD and HFD cells, respectively (p = 0.063; Fig. 2). Insulin stimulated 2-deoxyglucose uptake 3.7-fold in LFD cardiomyocytes and 2.2-fold in HFD cardiomyocytes (both p < 0.001 vs basal, p < 0.02 HFD vs LFD), indicating reduced myocardial insulin responsiveness. Oligomycin had similar stimulatory effects on 2-deoxyglucose uptake in HFD and LFD cardiomyocytes (HFD, 1.6-fold stimulation; LFD, 1.7-fold stimulation; both p < 0.05 vs basal). Fig. 2Rates of 2-deoxyglucose uptake in cardiomyocytes from rats fed the LFD (open bars) and the HFD (filled bars). Cardiomyocytes were incubated with DMSO (Basal), insulin (INS) or oligomycin (Oli) before measurement of 2-deoxyglucose uptake. Data are expressed as wet cell mass and are means+/-SE; n = 8. *p < 0.02, agonist effect; #p < 0.02, diet effectActivation of phosphatidylinositol 3'-kinase (PI3K)/protein kinase B (PKB/Akt)- and AMP-kinase (AMPK)-dependent signalling cascades has been implicated in the stimulation of glucose uptake in response to insulin and oligomycin, respectively. We studied whether changes in the activation of these signalling pathways paralleled the observed alterations in glucose uptake rates in HFD cells. Therefore, phosphorylation of PRAS40-Thr246 and ACC-Ser79 were examined as respective distal determinants for PKB/Akt and AMPK activity [13, 25], as the presence of bovine serum albumin (mol. mass 66 kDa) in the cardiomyocyte homogenates interfered with direct measurement of PKB/Akt (mol. mass 64 kDa) and AMPKalpha phosphorylation (mol. mass 62 kDa). Basal PRAS40-Thr246 phosphorylation was 1.7-fold higher in HFD than in LFD cells (p < 0.05; Fig. 3a,b). Insulin stimulated PRAS40-Thr246 phosphorylation 12.0-fold in LFD cells (p < 0.001) and 4.0-fold in HFD cells (p < 0.001), thus confirming reduced insulin responsiveness. Oligomycin did not affect PRAS40-Thr246 phosphorylation. Fig. 3Immunoblots (a, c) and quantification of PRAS40-Thr246 (b) and ACC-Ser79 (d) phosphorylation after incubation of cardiomyocytes from LFD- and HFD-fed rats with DMSO (Basal), insulin (INS) or oligomycin (Oli). Data are means+/-SE; n = 5. *p < 0.05, agonist effect; #p < 0.05, diet effectACC-Ser79 phosphorylation was measured as a determinant of AMPK activity [25]. Basal levels of Ser79-phosphorylated ACC were similar in LFD and HFD cells (Fig. 3c,d). Insulin had no effect on ACC-Ser79 phosphorylation, whereas oligomycin stimulated ACC-Ser79 phosphorylation in LFD and HFD cells to a similar extent (HFD, 3.0-fold stimulation; LFD, 2.9-fold stimulation; both p < 0.001 vs basal), indicating that AMPK signalling was not affected by high-fat feeding.
###end p 33
###begin p 34
###xml 19 23 <span type="species:ncbi:10116">rats</span>
Characteristics of rats after 10 weeks on a high- or low-fat diet
###end p 34
###begin p 35
Data are means+/-SE
###end p 35
###begin p 36
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
*p < 0.001 vs LFD
###end p 36
###begin p 37
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
**p < 0.02 vs LFD
###end p 37
###begin p 38
###xml 3 4 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
***p < 0.05 vs LFD
###end p 38
###begin p 39
###xml 72 81 72 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 96 107 96 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 151 156 151 156 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 168 171 168 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 188 191 188 191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 294 295 292 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 302 303 300 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 329 330 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Rates of 2-deoxyglucose uptake in cardiomyocytes from rats fed the LFD (open bars) and the HFD (filled bars). Cardiomyocytes were incubated with DMSO (Basal), insulin (INS) or oligomycin (Oli) before measurement of 2-deoxyglucose uptake. Data are expressed as wet cell mass and are means+/-SE; n = 8. *p < 0.02, agonist effect; #p < 0.02, diet effect
###end p 39
###begin p 40
###xml 13 14 13 14 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 16 17 16 17 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 56 57 56 57 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 74 75 74 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 183 186 183 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 203 206 203 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 230 231 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 238 239 236 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 265 266 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 150 154 <span type="species:ncbi:10116">rats</span>
Immunoblots (a, c) and quantification of PRAS40-Thr246 (b) and ACC-Ser79 (d) phosphorylation after incubation of cardiomyocytes from LFD- and HFD-fed rats with DMSO (Basal), insulin (INS) or oligomycin (Oli). Data are means+/-SE; n = 5. *p < 0.05, agonist effect; #p < 0.05, diet effect
###end p 40
###begin p 41
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HFD feeding results in increased CD36-mediated LCFA uptake</bold>
###xml 111 112 111 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 159 160 159 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 220 221 220 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 240 241 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 395 396 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 580 581 580 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 631 632 631 632 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 745 746 745 746 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 753 754 753 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 773 779 773 779 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;4</label>
###xml 806 807 806 807 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 821 822 821 822 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 898 899 898 899 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 938 947 938 947 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 967 978 967 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 1022 1027 1022 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 1039 1042 1039 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 1057 1060 1057 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 1152 1153 1150 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1160 1161 1158 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1187 1188 1185 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 779 1207 779 1205 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42">Rates of palmitate uptake (<bold>a</bold>), oxidation (<bold>b</bold>) and esterification into intracellular triacylglycerols and phospholipids (<bold>c</bold>) in cardiomyocytes from LFD-fed rats (<italic>open bars</italic>) and HFD-fed rats (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>), oligomycin (<italic>Oli</italic>) or SSO before measurement of palmitate uptake. Data are wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05 diet effect</p>
###xml 779 1207 779 1205 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42">Rates of palmitate uptake (<bold>a</bold>), oxidation (<bold>b</bold>) and esterification into intracellular triacylglycerols and phospholipids (<bold>c</bold>) in cardiomyocytes from LFD-fed rats (<italic>open bars</italic>) and HFD-fed rats (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>), oligomycin (<italic>Oli</italic>) or SSO before measurement of palmitate uptake. Data are wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05 diet effect</p></caption>
###xml 1207 1207 1205 1205 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig4_HTML" id="MO4"/>
###xml 773 1207 773 1205 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig4"><label>Fig.&#160;4</label><caption><p textid="42">Rates of palmitate uptake (<bold>a</bold>), oxidation (<bold>b</bold>) and esterification into intracellular triacylglycerols and phospholipids (<bold>c</bold>) in cardiomyocytes from LFD-fed rats (<italic>open bars</italic>) and HFD-fed rats (<italic>filled bars</italic>). Cardiomyocytes were incubated with DMSO (<italic>Basal</italic>), insulin (<italic>INS</italic>), oligomycin (<italic>Oli</italic>) or SSO before measurement of palmitate uptake. Data are wet cell mass and are means&#177;SE; <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, agonist effect; #<italic>p</italic>&#8201;&lt;&#8201;0.05 diet effect</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig4_HTML" id="MO4"/></fig>
###xml 1390 1391 1388 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1394 1395 1392 1393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1468 1469 1466 1467 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1488 1489 1486 1487 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1696 1697 1694 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1766 1767 1764 1765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 1841 1842 1839 1840 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2105 2106 2103 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2120 2121 2118 2119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 2180 2181 2178 2179 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2321 2322 2313 2314 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2332 2333 2324 2325 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 932 936 <span type="species:ncbi:10116">rats</span>
###xml 961 965 <span type="species:ncbi:10116">rats</span>
###xml 1981 1985 <span type="species:ncbi:10116">rats</span>
###xml 2272 2276 <span type="species:ncbi:10116">rats</span>
###xml 2315 2319 <span type="species:ncbi:10116">rats</span>
HFD feeding results in increased CD36-mediated LCFA uptake Basal rates of LCFA uptake were increased 1.4-fold (p < 0.001) in HFD compared with LFD cells (Fig. 4). The CD36 inhibitor SSO reduced basal LCFA uptake by 44% (p < 0.001) and 23% (p < 0.05) in HFD and LFD cardiomyocytes, respectively. Notably, the absolute rates of LCFA uptake were similar between SSO-treated LFD and HFD cells (Fig. 4), suggesting that the increased basal LCFA uptake rates in HFD cells can be ascribed to changes in the sarcolemmal pool of CD36. Insulin stimulated LCFA uptake 1.3-fold in LFD cells (p < 0.02 vs basal) but had no effect in HFD cells (p < 0.02 vs LFD; Fig. 4). Oligomycin increased LCFA uptake in LFD and HFD cardiomyocytes to the same extent (Fig. 4; both p < 0.05 vs basal). Fig. 4Rates of palmitate uptake (a), oxidation (b) and esterification into intracellular triacylglycerols and phospholipids (c) in cardiomyocytes from LFD-fed rats (open bars) and HFD-fed rats (filled bars). Cardiomyocytes were incubated with DMSO (Basal), insulin (INS), oligomycin (Oli) or SSO before measurement of palmitate uptake. Data are wet cell mass and are means+/-SE; n = 8. *p < 0.05, agonist effect; #p < 0.05 diet effectWe next examined the metabolic fate of LCFA following their uptake by HFD and LFD cardiomyocytes. Basal rates of LCFA oxidation were reduced by 22% in HFD relative to LFD cells (Fig. 4b; p < 0.01). SSO further lowered cardiomyocyte LCFA oxidation rates by 66% (p < 0.005) and 31% (p < 0.05) in LFD and HFD cells, respectively, but absolute rates of LCFA oxidation were comparable in SSO-treated LFD and HFD cells.The incorporation rate of LCFA into triacylglycerol was increased 1.4-fold (p < 0.05) in HFD compared with LFD cells under basal conditions (Fig. 4c). SSO reduced triacylglycerol formation in both LFD and HFD cells (both p < 0.05 vs basal). Notably, the absolute triacylglycerol esterification rates in SSO-treated cells did not differ between HFD- and LFD-fed rats. Also, the incorporation of LCFA into phospholipids under basal conditions was increased 1.5-fold in HFD vs LFD cells (p < 0.05; Fig. 4c), and was reduced by SSO in both LFD and HFD cells (both p < 0.05 vs basal). Myocardial triacylglycerol content was 181 +/- 50 mug/mg protein in LFD rats and 330 +/- 114 mug/mg protein in HFD rats (p < 0.02) [2].
###end p 41
###begin p 42
###xml 27 28 27 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 42 43 42 43 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 119 120 119 120 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 159 168 159 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 188 199 188 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 243 248 243 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Basal</italic>
###xml 260 263 260 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">INS</italic>
###xml 278 281 278 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Oli</italic>
###xml 373 374 371 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 381 382 379 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 408 409 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 153 157 <span type="species:ncbi:10116">rats</span>
###xml 182 186 <span type="species:ncbi:10116">rats</span>
Rates of palmitate uptake (a), oxidation (b) and esterification into intracellular triacylglycerols and phospholipids (c) in cardiomyocytes from LFD-fed rats (open bars) and HFD-fed rats (filled bars). Cardiomyocytes were incubated with DMSO (Basal), insulin (INS), oligomycin (Oli) or SSO before measurement of palmitate uptake. Data are wet cell mass and are means+/-SE; n = 8. *p < 0.05, agonist effect; #p < 0.05 diet effect
###end p 42
###begin p 43
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HFD induces cardiomyocyte hypertrophy and alters the subcellular localisation of CD36</bold>
###xml 361 362 361 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 504 505 504 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 527 528 527 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 684 685 684 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 707 708 707 708 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 722 723 722 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 726 732 726 732 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;5</label>
###xml 939 940 939 940 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1046 1047 1046 1047 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1049 1050 1049 1050 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1060 1061 1060 1061 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1063 1064 1063 1064 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1122 1123 1122 1123 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1125 1126 1125 1126 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1140 1141 1140 1141 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1143 1144 1143 1144 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 1279 1285 1279 1285 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 1315 1324 1315 1324 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 732 1341 732 1340 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="44">Expression and subcellular localisation of CD36. Expression of CD36 in ventricular lysates of HFD and LFD rats. Ponceau S staining confirmed that the filters contained equal amounts of ventricular extracts (<bold>a</bold>). Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from rats fed an LFD (<bold>b</bold>, <bold>d</bold>) or HFD (<bold>c</bold>, <bold>e</bold>) for 8&#160;weeks. Rats received an i.p. injection of saline (<bold>b</bold>, <bold>c</bold>) or insulin (<bold>d</bold>, <bold>e</bold>) 30&#160;min before killing. Photographs are representative of two independent experiments performed on three rats per experimental group. <italic>Arrows</italic> indicate intercalated discs. <italic>Scale bar</italic> indicates 25&#160;&#956;m</p>
###xml 732 1341 732 1340 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="44">Expression and subcellular localisation of CD36. Expression of CD36 in ventricular lysates of HFD and LFD rats. Ponceau S staining confirmed that the filters contained equal amounts of ventricular extracts (<bold>a</bold>). Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from rats fed an LFD (<bold>b</bold>, <bold>d</bold>) or HFD (<bold>c</bold>, <bold>e</bold>) for 8&#160;weeks. Rats received an i.p. injection of saline (<bold>b</bold>, <bold>c</bold>) or insulin (<bold>d</bold>, <bold>e</bold>) 30&#160;min before killing. Photographs are representative of two independent experiments performed on three rats per experimental group. <italic>Arrows</italic> indicate intercalated discs. <italic>Scale bar</italic> indicates 25&#160;&#956;m</p></caption>
###xml 1341 1341 1340 1340 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig5_HTML" id="MO5"/>
###xml 726 1341 726 1340 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig5"><label>Fig.&#160;5</label><caption><p textid="44">Expression and subcellular localisation of CD36. Expression of CD36 in ventricular lysates of HFD and LFD rats. Ponceau S staining confirmed that the filters contained equal amounts of ventricular extracts (<bold>a</bold>). Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from rats fed an LFD (<bold>b</bold>, <bold>d</bold>) or HFD (<bold>c</bold>, <bold>e</bold>) for 8&#160;weeks. Rats received an i.p. injection of saline (<bold>b</bold>, <bold>c</bold>) or insulin (<bold>d</bold>, <bold>e</bold>) 30&#160;min before killing. Photographs are representative of two independent experiments performed on three rats per experimental group. <italic>Arrows</italic> indicate intercalated discs. <italic>Scale bar</italic> indicates 25&#160;&#956;m</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig5_HTML" id="MO5"/></fig>
###xml 1341 1348 1340 1347 <label xmlns:xlink="http://www.w3.org/1999/xlink">Table&#160;3</label>
###xml 1348 1403 1347 1402 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="45">Cardiac morphology and subcellular localisation of CD36</p>
###xml 1348 1403 1347 1402 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="45">Cardiac morphology and subcellular localisation of CD36</p></caption>
###xml 1403 1404 1402 1403 <th xmlns:xlink="http://www.w3.org/1999/xlink" rowspan="2">&#160;</th>
###xml 1404 1407 1403 1406 <th xmlns:xlink="http://www.w3.org/1999/xlink">LFD</th>
###xml 1407 1410 1406 1409 <th xmlns:xlink="http://www.w3.org/1999/xlink">HFD</th>
###xml 1403 1410 1402 1409 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr>
###xml 1411 1412 1410 1411 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1410 1417 1409 1416 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;6)</th>
###xml 1418 1419 1417 1418 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1417 1424 1416 1423 <th xmlns:xlink="http://www.w3.org/1999/xlink">(<italic>n</italic>&#8201;=&#8201;8)</th>
###xml 1410 1424 1409 1423 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><th>(<italic>n</italic>&#8201;=&#8201;6)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th></tr>
###xml 1403 1424 1402 1423 <thead xmlns:xlink="http://www.w3.org/1999/xlink"><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;6)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th></tr></thead>
###xml 1424 1434 1423 1433 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">Morphology</td>
###xml 1424 1434 1423 1433 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">Morphology</td></tr>
###xml 1505 1506 1503 1504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2</sup>
###xml 1434 1507 1433 1505 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;Cardiomyocyte cross-sectional area normalised to sarcomere length (&#956;m<sup>2</sup>)</td>
###xml 1507 1518 1505 1514 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">214&#8201;&#177;&#8201;3.5</td>
###xml 1518 1529 1514 1523 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">276&#8201;&#177;&#8201;23*</td>
###xml 1434 1529 1433 1523 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;Cardiomyocyte cross-sectional area normalised to sarcomere length (&#956;m<sup>2</sup>)</td><td align="center">214&#8201;&#177;&#8201;3.5</td><td align="center">276&#8201;&#177;&#8201;23*</td></tr>
###xml 1529 1546 1523 1540 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">CD36 localisation</td>
###xml 1529 1546 1523 1540 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">CD36 localisation</td></tr>
###xml 1546 1557 1540 1551 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">&#160;Sarcolemma</td>
###xml 1546 1557 1540 1551 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">&#160;Sarcolemma</td></tr>
###xml 1557 1569 1551 1563 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#160;Saline (%)</td>
###xml 1569 1579 1563 1571 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">61.7&#8201;&#177;&#8201;3</td>
###xml 1579 1591 1571 1581 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">74.8&#8201;&#177;&#8201;1**</td>
###xml 1557 1591 1551 1581 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#160;Saline (%)</td><td align="center">61.7&#8201;&#177;&#8201;3</td><td align="center">74.8&#8201;&#177;&#8201;1**</td></tr>
###xml 1591 1604 1581 1594 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#160;Insulin (%)</td>
###xml 1604 1617 1594 1605 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">75.9&#8201;&#177;&#8201;4***</td>
###xml 1617 1627 1605 1613 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">78.2&#8201;&#177;&#8201;3</td>
###xml 1591 1627 1581 1613 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#160;Insulin (%)</td><td align="center">75.9&#8201;&#177;&#8201;4***</td><td align="center">78.2&#8201;&#177;&#8201;3</td></tr>
###xml 1627 1637 1613 1623 <td xmlns:xlink="http://www.w3.org/1999/xlink" colspan="3">&#160;Cytoplasm</td>
###xml 1627 1637 1613 1623 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td colspan="3">&#160;Cytoplasm</td></tr>
###xml 1637 1649 1623 1635 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#160;Saline (%)</td>
###xml 1649 1659 1635 1643 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">38.3&#8201;&#177;&#8201;3</td>
###xml 1659 1671 1643 1653 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">25.2&#8201;&#177;&#8201;1**</td>
###xml 1637 1671 1623 1653 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#160;Saline (%)</td><td align="center">38.3&#8201;&#177;&#8201;3</td><td align="center">25.2&#8201;&#177;&#8201;1**</td></tr>
###xml 1671 1684 1653 1666 <td xmlns:xlink="http://www.w3.org/1999/xlink">&#160;&#160;Insulin (%)</td>
###xml 1684 1697 1666 1677 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">24.1&#8201;&#177;&#8201;4***</td>
###xml 1697 1707 1677 1685 <td xmlns:xlink="http://www.w3.org/1999/xlink" align="center">21.8&#8201;&#177;&#8201;3</td>
###xml 1671 1707 1653 1685 <tr xmlns:xlink="http://www.w3.org/1999/xlink"><td>&#160;&#160;Insulin (%)</td><td align="center">24.1&#8201;&#177;&#8201;4***</td><td align="center">21.8&#8201;&#177;&#8201;3</td></tr>
###xml 1424 1707 1423 1685 <tbody xmlns:xlink="http://www.w3.org/1999/xlink"><tr><td colspan="3">Morphology</td></tr><tr><td>&#160;Cardiomyocyte cross-sectional area normalised to sarcomere length (&#956;m<sup>2</sup>)</td><td align="center">214&#8201;&#177;&#8201;3.5</td><td align="center">276&#8201;&#177;&#8201;23*</td></tr><tr><td colspan="3">CD36 localisation</td></tr><tr><td colspan="3">&#160;Sarcolemma</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">61.7&#8201;&#177;&#8201;3</td><td align="center">74.8&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">75.9&#8201;&#177;&#8201;4***</td><td align="center">78.2&#8201;&#177;&#8201;3</td></tr><tr><td colspan="3">&#160;Cytoplasm</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">38.3&#8201;&#177;&#8201;3</td><td align="center">25.2&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">24.1&#8201;&#177;&#8201;4***</td><td align="center">21.8&#8201;&#177;&#8201;3</td></tr></tbody>
###xml 1403 1707 1402 1685 <table xmlns:xlink="http://www.w3.org/1999/xlink" frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;6)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th></tr></thead><tbody><tr><td colspan="3">Morphology</td></tr><tr><td>&#160;Cardiomyocyte cross-sectional area normalised to sarcomere length (&#956;m<sup>2</sup>)</td><td align="center">214&#8201;&#177;&#8201;3.5</td><td align="center">276&#8201;&#177;&#8201;23*</td></tr><tr><td colspan="3">CD36 localisation</td></tr><tr><td colspan="3">&#160;Sarcolemma</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">61.7&#8201;&#177;&#8201;3</td><td align="center">74.8&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">75.9&#8201;&#177;&#8201;4***</td><td align="center">78.2&#8201;&#177;&#8201;3</td></tr><tr><td colspan="3">&#160;Cytoplasm</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">38.3&#8201;&#177;&#8201;3</td><td align="center">25.2&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">24.1&#8201;&#177;&#8201;4***</td><td align="center">21.8&#8201;&#177;&#8201;3</td></tr></tbody></table>
###xml 1707 1726 1685 1702 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="46">Data are means&#177;SE</p>
###xml 1727 1728 1703 1704 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1726 1742 1702 1718 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="47">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p>
###xml 1744 1745 1720 1721 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1742 1760 1718 1736 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="48">**<italic>p</italic>&#8201;&lt;&#8201;0.002 vs LFD</p>
###xml 1763 1764 1739 1740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1760 1781 1736 1757 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="49">***<italic>p</italic>&#8201;&lt;&#8201;0.01 vs saline</p>
###xml 1707 1781 1685 1757 <table-wrap-foot xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="46">Data are means&#177;SE</p><p textid="47">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p><p textid="48">**<italic>p</italic>&#8201;&lt;&#8201;0.002 vs LFD</p><p textid="49">***<italic>p</italic>&#8201;&lt;&#8201;0.01 vs saline</p></table-wrap-foot>
###xml 1341 1781 1340 1757 <table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" id="Tab3"><label>Table&#160;3</label><caption><p textid="45">Cardiac morphology and subcellular localisation of CD36</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="2">&#160;</th><th>LFD</th><th>HFD</th></tr><tr><th>(<italic>n</italic>&#8201;=&#8201;6)</th><th>(<italic>n</italic>&#8201;=&#8201;8)</th></tr></thead><tbody><tr><td colspan="3">Morphology</td></tr><tr><td>&#160;Cardiomyocyte cross-sectional area normalised to sarcomere length (&#956;m<sup>2</sup>)</td><td align="center">214&#8201;&#177;&#8201;3.5</td><td align="center">276&#8201;&#177;&#8201;23*</td></tr><tr><td colspan="3">CD36 localisation</td></tr><tr><td colspan="3">&#160;Sarcolemma</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">61.7&#8201;&#177;&#8201;3</td><td align="center">74.8&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">75.9&#8201;&#177;&#8201;4***</td><td align="center">78.2&#8201;&#177;&#8201;3</td></tr><tr><td colspan="3">&#160;Cytoplasm</td></tr><tr><td>&#160;&#160;Saline (%)</td><td align="center">38.3&#8201;&#177;&#8201;3</td><td align="center">25.2&#8201;&#177;&#8201;1**</td></tr><tr><td>&#160;&#160;Insulin (%)</td><td align="center">24.1&#8201;&#177;&#8201;4***</td><td align="center">21.8&#8201;&#177;&#8201;3</td></tr></tbody></table><table-wrap-foot><p textid="46">Data are means&#177;SE</p><p textid="47">*<italic>p</italic>&#8201;&lt;&#8201;0.05 vs LFD</p><p textid="48">**<italic>p</italic>&#8201;&lt;&#8201;0.002 vs LFD</p><p textid="49">***<italic>p</italic>&#8201;&lt;&#8201;0.01 vs saline</p></table-wrap-foot></table-wrap>
###xml 1848 1849 1824 1825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig4" ref-type="fig">4</xref>
###xml 2007 2008 1983 1984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 2018 2019 1994 1995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 2131 2132 2107 2108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 2157 2158 2133 2134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab3" ref-type="table">3</xref>
###xml 2237 2238 2213 2214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 838 842 <span type="species:ncbi:10116">rats</span>
###xml 1029 1033 <span type="species:ncbi:10116">rats</span>
###xml 1079 1083 <span type="species:ncbi:10116">Rats</span>
###xml 1250 1254 <span type="species:ncbi:10116">rats</span>
HFD induces cardiomyocyte hypertrophy and alters the subcellular localisation of CD36 The inhibitory effect of SSO suggests that the increased basal LCFA uptake and esterification rates in HFD cells can be ascribed to changes in the sarcolemmal pool of CD36. Western blot analysis indicated that the levels of CD36 were similar between HFD and LFD hearts (Fig. 5a). Immunohistochemical staining of cardiac LV tissue indicated cardiomyocyte hypertrophy, as reflected by an increased cross-sectional area (p < 0.05 vs LFD; Table 3), and showed a more abundant presence of CD36 at the sarcolemmal membrane, particularly at the intercalated discs, in HFD hearts compared with LFD hearts (p < 0.002 vs LFD; Fig. 5b,c and Table 3). Fig. 5Expression and subcellular localisation of CD36. Expression of CD36 in ventricular lysates of HFD and LFD rats. Ponceau S staining confirmed that the filters contained equal amounts of ventricular extracts (a). Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from rats fed an LFD (b, d) or HFD (c, e) for 8 weeks. Rats received an i.p. injection of saline (b, c) or insulin (d, e) 30 min before killing. Photographs are representative of two independent experiments performed on three rats per experimental group. Arrows indicate intercalated discs. Scale bar indicates 25 mumTable 3Cardiac morphology and subcellular localisation of CD36 LFDHFD(n = 6)(n = 8)Morphology Cardiomyocyte cross-sectional area normalised to sarcomere length (mum2)214 +/- 3.5276 +/- 23*CD36 localisation Sarcolemma  Saline (%)61.7 +/- 374.8 +/- 1**  Insulin (%)75.9 +/- 4***78.2 +/- 3 Cytoplasm  Saline (%)38.3 +/- 325.2 +/- 1**  Insulin (%)24.1 +/- 4***21.8 +/- 3Data are means+/-SE*p < 0.05 vs LFD**p < 0.002 vs LFD***p < 0.01 vs salineAs insulin stimulated LCFA uptake in isolated cardiomyocytes (Fig. 4), we also examined the subcellular localisation of CD36 in hearts isolated 30 min following an intraperitoneal injection with insulin (10 U/kg body weight) [2]. Figure 5d shows that in vivo insulin treatment increased CD36 immunoreactivity at the intercalated discs in LFD hearts (p < 0.01 vs saline; Table 3). In HFD hearts, insulin did not further recruit CD36 to the sarcolemma (Fig. 5e).
###end p 43
###begin p 44
###xml 207 208 207 208 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 314 315 314 315 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 317 318 317 318 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 328 329 328 329 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 331 332 331 332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 390 391 390 391 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 393 394 393 394 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 408 409 408 409 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 411 412 411 412 <bold xmlns:xlink="http://www.w3.org/1999/xlink">e</bold>
###xml 547 553 547 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Arrows</italic>
###xml 583 592 583 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Scale bar</italic>
###xml 106 110 <span type="species:ncbi:10116">rats</span>
###xml 297 301 <span type="species:ncbi:10116">rats</span>
###xml 347 351 <span type="species:ncbi:10116">Rats</span>
###xml 518 522 <span type="species:ncbi:10116">rats</span>
Expression and subcellular localisation of CD36. Expression of CD36 in ventricular lysates of HFD and LFD rats. Ponceau S staining confirmed that the filters contained equal amounts of ventricular extracts (a). Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from rats fed an LFD (b, d) or HFD (c, e) for 8 weeks. Rats received an i.p. injection of saline (b, c) or insulin (d, e) 30 min before killing. Photographs are representative of two independent experiments performed on three rats per experimental group. Arrows indicate intercalated discs. Scale bar indicates 25 mum
###end p 44
###begin p 45
Cardiac morphology and subcellular localisation of CD36
###end p 45
###begin p 46
Data are means+/-SE
###end p 46
###begin p 47
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
*p < 0.05 vs LFD
###end p 47
###begin p 48
###xml 2 3 2 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
**p < 0.002 vs LFD
###end p 48
###begin p 49
###xml 3 4 3 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
***p < 0.01 vs saline
###end p 49
###begin p 50
###xml 0 165 0 165 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HFD-induced CD36 redistribution to the sarcolemma precedes the onset of cardiac contractile dysfunction and associates with elevated basal phosphorylation of PKB/Akt</bold>
###xml 561 562 561 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 762 763 762 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 778 779 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Tab1" ref-type="table">1</xref>
###xml 1024 1025 1024 1025 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 1108 1109 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 1115 1121 1115 1121 <label xmlns:xlink="http://www.w3.org/1999/xlink">Fig.&#160;6</label>
###xml 1331 1332 1331 1332 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 1342 1343 1342 1343 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 1479 1485 1479 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 1519 1528 1519 1528 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bar</italic>
###xml 1547 1548 1546 1547 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 1579 1580 1578 1579 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 1687 1696 1686 1695 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 1706 1717 1705 1716 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 1773 1774 1770 1771 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 1781 1782 1778 1779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 1121 1802 1121 1799 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="51">Effect of the duration of HFD feeding on CD36 localisation and phosphorylation of PKB/Akt. Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from saline-injected rats fed an LFD (<bold>a</bold>) or HFD (<bold>b</bold>) for 4&#160;weeks. Photographs are representative of two or three independent experiments performed on six rats per experimental group. The <italic>arrows</italic> indicate intercalated discs. The <italic>scale bar</italic> indicates 25&#160;&#956;m. <bold>c</bold> Immunoblot and quantification <bold>d</bold> of PKB/Akt-Ser473 phosphorylation levels in ventricular homogenates from saline-injected rats fed an LFD (<italic>open bars</italic>) or HFD (<italic>filled bars</italic>) for 4 and 8&#160;weeks, respectively. Data are means&#177;SE, <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p>
###xml 1121 1802 1121 1799 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="51">Effect of the duration of HFD feeding on CD36 localisation and phosphorylation of PKB/Akt. Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from saline-injected rats fed an LFD (<bold>a</bold>) or HFD (<bold>b</bold>) for 4&#160;weeks. Photographs are representative of two or three independent experiments performed on six rats per experimental group. The <italic>arrows</italic> indicate intercalated discs. The <italic>scale bar</italic> indicates 25&#160;&#956;m. <bold>c</bold> Immunoblot and quantification <bold>d</bold> of PKB/Akt-Ser473 phosphorylation levels in ventricular homogenates from saline-injected rats fed an LFD (<italic>open bars</italic>) or HFD (<italic>filled bars</italic>) for 4 and 8&#160;weeks, respectively. Data are means&#177;SE, <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p></caption>
###xml 1802 1802 1799 1799 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" xlink:href="125_2007_735_Fig6_HTML" id="MO6"/>
###xml 1115 1802 1115 1799 <fig xmlns:xlink="http://www.w3.org/1999/xlink" id="Fig6"><label>Fig.&#160;6</label><caption><p textid="51">Effect of the duration of HFD feeding on CD36 localisation and phosphorylation of PKB/Akt. Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from saline-injected rats fed an LFD (<bold>a</bold>) or HFD (<bold>b</bold>) for 4&#160;weeks. Photographs are representative of two or three independent experiments performed on six rats per experimental group. The <italic>arrows</italic> indicate intercalated discs. The <italic>scale bar</italic> indicates 25&#160;&#956;m. <bold>c</bold> Immunoblot and quantification <bold>d</bold> of PKB/Akt-Ser473 phosphorylation levels in ventricular homogenates from saline-injected rats fed an LFD (<italic>open bars</italic>) or HFD (<italic>filled bars</italic>) for 4 and 8&#160;weeks, respectively. Data are means&#177;SE, <italic>n</italic>&#8201;=&#8201;8. *<italic>p</italic>&#8201;&lt;&#8201;0.05, diet effect</p></caption><graphic position="anchor" xlink:href="125_2007_735_Fig6_HTML" id="MO6"/></fig>
###xml 2066 2068 2063 2065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 2150 2151 2147 2148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig5" ref-type="fig">5</xref>
###xml 2426 2427 2423 2424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="Fig6" ref-type="fig">6</xref>
###xml 2549 2550 2546 2547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 296 300 <span type="species:ncbi:10116">rats</span>
###xml 1314 1318 <span type="species:ncbi:10116">rats</span>
###xml 1446 1450 <span type="species:ncbi:10116">rats</span>
###xml 1670 1674 <span type="species:ncbi:10116">rats</span>
###xml 2363 2367 <span type="species:ncbi:10116">rats</span>
HFD-induced CD36 redistribution to the sarcolemma precedes the onset of cardiac contractile dysfunction and associates with elevated basal phosphorylation of PKB/Akt We next analysed whether HFD-induced alterations in CD36 localisation precede the onset of cardiac contractile dysfunction, using rats fed an LFD or HFD for 4 weeks. This period was chosen based on serial echocardiographic measurements, which revealed a tendency towards decreased cardiac contractile function 4 weeks after initiation of the diet intervention. Specifically, FS% was 4.2% lower (p = 0.07) and EF% was 3.3% lower (p = 0.10) in HFD vs LFD hearts after 4 weeks on the diet (data not shown), compared with the 9.2 and 6.2% decreases observed after 8 weeks of the feeding regime (both p < 0.05; Table 1). Despite the absence of significant effects on cardiac function after 4 weeks of HFD feeding, immunohistochemical staining of cardiac LV tissue showed that the abundance of CD36 at the sarcolemmal membrane was already markedly increased (Fig. 6a,b) to levels almost similar to those observed after 8 weeks of HFD feeding (Fig. 5b,c). Fig. 6Effect of the duration of HFD feeding on CD36 localisation and phosphorylation of PKB/Akt. Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from saline-injected rats fed an LFD (a) or HFD (b) for 4 weeks. Photographs are representative of two or three independent experiments performed on six rats per experimental group. The arrows indicate intercalated discs. The scale bar indicates 25 mum. c Immunoblot and quantification d of PKB/Akt-Ser473 phosphorylation levels in ventricular homogenates from saline-injected rats fed an LFD (open bars) or HFD (filled bars) for 4 and 8 weeks, respectively. Data are means+/-SE, n = 8. *p < 0.05, diet effectFinally, we analysed whether HFD feeding induced changes in the activity of signalling pathways implicated in CD36 trafficking. In the healthy myocardium, CD36 is stored in at least two endosomal storage pools that are regulated by AMPK and PKB/Akt, respectively [26]. As insulin does not further recruit CD36 to the sarcolemma in HFD hearts (Fig. 5e), we proposed that increases in basal activity of PKB/Akt may underlie the redistribution of CD36 in HFD hearts. Phosphorylation of PKB/Akt was determined in LV homogenates of the same group of saline-injected rats in which CD36 localisation was measured. As shown in Fig. 6c,d, basal phosphorylation of PKB/Akt was 1.7- and 2.6-fold higher after 4 and 8 weeks of HFD feeding, respectively (both p < 0.05). Collectively, these results indicate that increased activity of PKB/Akt may underlie CD36 redistribution to the sarcolemma, and that these events precede the LV dysfunction induced by HFD feeding.
###end p 50
###begin p 51
###xml 210 211 210 211 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 221 222 221 222 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 358 364 358 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink">arrows</italic>
###xml 398 407 398 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">scale bar</italic>
###xml 426 427 425 426 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 458 459 457 458 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 566 575 565 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">open bars</italic>
###xml 585 596 584 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink">filled bars</italic>
###xml 652 653 649 650 <italic xmlns:xlink="http://www.w3.org/1999/xlink">n</italic>
###xml 660 661 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p</italic>
###xml 193 197 <span type="species:ncbi:10116">rats</span>
###xml 325 329 <span type="species:ncbi:10116">rats</span>
###xml 549 553 <span type="species:ncbi:10116">rats</span>
Effect of the duration of HFD feeding on CD36 localisation and phosphorylation of PKB/Akt. Immunohistochemical staining for CD36 localisation of cardiac LV tissue sections from saline-injected rats fed an LFD (a) or HFD (b) for 4 weeks. Photographs are representative of two or three independent experiments performed on six rats per experimental group. The arrows indicate intercalated discs. The scale bar indicates 25 mum. c Immunoblot and quantification d of PKB/Akt-Ser473 phosphorylation levels in ventricular homogenates from saline-injected rats fed an LFD (open bars) or HFD (filled bars) for 4 and 8 weeks, respectively. Data are means+/-SE, n = 8. *p < 0.05, diet effect
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 75 79 <span type="species:ncbi:10116">rats</span>
Here we report that HFD feeding induces cardiac contractile dysfunction in rats and that this is associated with a permanent relocation of CD36 to the sarcolemma. The continuous presence of CD36 at the sarcolemmal membrane results in enhanced rates of LCFA uptake and subsequent esterification. We propose that this contributes to a decrease in myocardial insulin action and the development of diabetes-related heart disease. In addition, we show that AMPK-mediated responses are not affected by the composition of the diet.
###end p 53
###begin p 54
###xml 647 651 <span type="species:ncbi:10116">rats</span>
A key observation in this study is that the alterations in cardiac contractile function in HFD hearts was associated with a continuous presence of CD36 at the sarcolemmal membrane. The present study provides the first morphological evidence for translocation of CD36 to the sarcolemmal membrane. Importantly, the amount of sarcolemmal CD36 closely correlated with enhanced LCFA uptake rates in isolated cardiomyocytes. The observation that SSO inhibited LCFA uptake in HFD cardiomyocytes to the same residual levels as measured in LFD cardiomyocytes provides further pharmacological evidence that the enhanced flux of LCFA in the heart of HFD-fed rats is a direct consequence of the relocalisation of CD36 to the sarcolemmal membrane.
###end p 54
###begin p 55
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR27">27</xref>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR28">28</xref>
###xml 954 955 954 955 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 957 959 957 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 1030 1031 1030 1031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 1033 1035 1033 1035 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR22">22</xref>
###xml 865 869 <span type="species:ncbi:10116">rats</span>
Previously, a redistribution of CD36 to both subsarcolemmal and intramyofibrillar mitochondria has also been observed [27, 28]. Can the observed CD36 immunoreactivity be ascribed to subsarcolemmal mitochondria rather that the sarcolemma itself? Stimuli inducing translocation of CD36 to the mitochondria are expected not to discriminate between the subsarcolemmal and the intramyofibrillar mitochondria. Hence, if a stimulus or condition, in this case insulin or HFD feeding, were to increase the subsarcolemmal CD36 content, one would expect a similar increase in intramyofibrillar CD36 content. This, however, could not be confirmed in the immunohistochemical experiments. Furthermore, biochemical fractionations performed in previous studies substantiate the idea that a significant fraction of CD36 is present at the sarcolemma of hearts from insulin-resistant rats, and that only a minor portion of CD36 is found within the mitochondrial fractions [9, 22]. While insulin has been shown to translocate CD36 to the sarcolemma [9, 22], insulin-mediated CD36 translocation to the mitochondria has never been reported and even seems counterintuitive. Collectively, the available evidence strongly supports the idea that the observed CD36 immunoreactivity can be ascribed to CD36 located at the sarcolemma rather than in subsarcolemmal mitochondria.
###end p 55
###begin p 56
###xml 70 71 70 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 430 432 430 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR10">10</xref>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR14">14</xref>
###xml 607 609 607 609 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 1243 1245 1243 1245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR11">11</xref>
###xml 1247 1249 1247 1249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR26">26</xref>
###xml 64 68 <span type="species:ncbi:10116">rats</span>
###xml 810 814 <span type="species:ncbi:10116">rats</span>
###xml 1063 1067 <span type="species:ncbi:10116">rats</span>
###xml 1425 1429 <span type="species:ncbi:10116">rats</span>
The combined data of this and our earlier study on obese Zucker rats [9] suggest that relocalisation of CD36 is a general phenomenon in insulin-resistant hearts, and raises the question of what mechanism underlies the continuous presence of CD36 at the sarcolemmal membrane in HFD hearts. In the healthy myocardium, CD36 is stored in at least two endosomal storage pools that are regulated by AMPK and PI3K/PKB/Akt, respectively [26]. Activation of AMPK is critical for contraction- and oligomycin-mediated CD36 translocation, whereas PI3K/PKB/Akt is critical for insulin-mediated CD36 trafficking [10, 14, 26]. Basal phosphorylation of PKB/Akt and its distal target, PRAS40, were elevated in HFD compared with LFD hearts, whereas AMPK activity was not affected by the diet. Furthermore, in cells from HFD-fed rats, the stimulatory effects of insulin on LCFA uptake, CD36 translocation and phosphorylation of PKB/Akt and PRAS40 were abrogated, whereas oligomycin-induced AMPK activation and LCFA uptake was unimpaired between cardiomyocytes from LFD- and HFD-fed rats. Although we cannot exclude a contribution of other kinases or HFD-induced alterations in the as yet undisclosed trafficking machinery regulating the internalisation of CD36 [11, 26], our observations do not argue against the suggestion that increases in PKB/Akt activity may contribute to the sustained sarcolemmal presence of CD36 in the heart of HFD-fed rats.
###end p 56
###begin p 57
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR9">9</xref>
###xml 197 198 197 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 200 202 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 413 415 406 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 504 506 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR29">29</xref>
###xml 123 127 <span type="species:ncbi:10116">rats</span>
###xml 191 195 <span type="species:ncbi:10116">rats</span>
Previously, we suggested that increased plasma insulin might contribute to CD36 relocalisation in hearts from obese Zucker rats [9]. As systemic hyperinsulinaemia was not observed in HFD-fed rats [2, 13], it remains interesting to examine whether changes in the activity of other (insulin-independent) regulators of PKB/Akt phosphorylation, such as PI3Kgamma- and beta2-adrenergic receptor signalling pathways, Ca2+-calmodulin dependent kinase, protein phosphatase 2A and the sympathetic nervous system [29], can be linked to the observed increase in PKB/Akt phosphorylation in HFD hearts.
###end p 57
###begin p 58
###xml 564 565 564 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="" rid="MOESM1">1</xref>
###xml 681 683 681 683 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR30">30</xref>
###xml 440 444 <span type="species:ncbi:10116">rats</span>
###xml 636 640 <span type="species:ncbi:10116">rats</span>
###xml 844 848 <span type="species:ncbi:10116">rats</span>
The metabolic and biochemical data were paralleled by in vivo cardiac functional changes. Importantly, HFD-induced cardiac contractile dysfunction does not seem to be linked to diet-related elevations in blood pressure. Circadian haemodynamic parameters were monitored using implanted telemetry devices in an experiment performed in a separate group of animals. We found a slight increase in night-time (activity-related) heart rate in HFD rats, but no changes in blood pressure even after 10 weeks of exposure to the diet (Electronic supplementary material Table 1). Others confirmed the absence of relevant hypertension after feeding rats a diet containing 74% fat for 17 weeks [30]. This underscores the possibility that alterations in metabolism, rather than in haemodynamics, underlie the impairment in cardiac contractile function in HFD rats.
###end p 58
###begin p 59
###xml 566 567 566 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 928 929 928 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 922 926 <span type="species:ncbi:10116">rats</span>
###xml 1029 1037 <span type="species:ncbi:9606">patients</span>
The present study also suggests that HFD-induced alterations in the functional pool of CD36 may contribute to an imbalance in LCFA uptake and in oxidation and esterification rates in HFD vs LFD cells. Whereas LCFA uptake rates were increased 1.4-fold in HFD cells, the LCFA oxidation rates were not increased but rather modestly lower in HFD cells, while the rates of esterification into triacylglycerol and phospholipids were 1.4-fold higher in HFD vs LFD cardiomyocytes. Accordingly, triacylglycerol content was 1.9-fold increased in HFD compared with LFD hearts [2]. It seems unlikely that changes in malonylCoA levels underlie the reduced rates of LCFA oxidation in HFD hearts, as no diet-induced changes in ACC phosphorylation were found. Rather, degenerative changes in mitochondria, such as matrix dilution, cristolysis and mitochondria-associated lamellar bodies, have been observed in cardiomyocytes from HFD-fed rats [2] and have been linked to reduced oxidative capacity and lipid accumulation in skeletal muscle from patients with type 2 diabetes. However, further studies are required to examine whether these changes contribute to the reduced basal LCFA oxidation and increased LCFA esterification rates, or whether the extra LCFA taken up by HFD cells are stored as triacylglycerol and phospholipids as a consequence of HFD-induced changes in enzymes promoting LCFA esterification or inhibition of lipolysis.
###end p 59
###begin p 60
###xml 466 468 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR12">12</xref>
###xml 555 557 551 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 712 714 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR32">32</xref>
###xml 716 718 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 905 907 901 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR31">31</xref>
###xml 909 911 905 907 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR34">34</xref>
###xml 1003 1005 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 1169 1171 1165 1167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR36">36</xref>
###xml 359 374 <span type="species:ncbi:10090">transgenic mice</span>
###xml 600 608 <span type="species:ncbi:9606">patients</span>
###xml 736 741 <span type="species:ncbi:10090">mouse</span>
An important finding of this study is that the HFD-induced CD36 redistribution preceded the onset of cardiac contractile dysfunction. Although we cannot unequivocally link CD36 redistribution to cardiac dysfunction, a recent report provided strong support for this notion as the absence of CD36 was found to prevent myocardial triacylglycerol accumulation in transgenic mice with cardiac PPARalpha overexpression, both under normal conditions and after HFD feeding [12]. Similarly, alterations in PKB/Akt activity have been linked to cardiac dysfunction [31]. Myocardial biopsy samples obtained from patients with advanced heart failure or dilated cardiomyopathy show increased basal phosphorylation of PKB/Akt [32, 33], and transgenic mouse models with constitutively activated PKB/Akt in the heart develop hypertrophy, decreased cardiac function and impaired recovery from ischaemia-reperfusion injury [31, 34]. Whereas chronic activation of PKB/Akt increases basal glucose uptake rates in the heart [35], the effects on myocardial lipid metabolism have not been studied. Interestingly, PKB/Akt signalling has been linked to palmitate-induced beta cell lipotoxicity [36]. Based on this report and the findings described in this study, it would be of interest to analyse animals expressing chronically active PKB/Akt for translocation of CD36 to the sarcolemma and myocardial lipid accumulation.
###end p 60
###begin p 61
###xml 259 261 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 272 274 272 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR37">37</xref>
###xml 276 278 276 278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR38">38</xref>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR1">1</xref>
###xml 404 405 404 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 407 408 407 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR8">8</xref>
###xml 812 814 808 810 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR39">39</xref>
###xml 816 818 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR40">40</xref>
###xml 948 950 944 946 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR33">33</xref>
###xml 1003 1005 999 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR35">35</xref>
###xml 1145 1147 1141 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR41">41</xref>
###xml 1186 1187 1182 1183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR2">2</xref>
###xml 1189 1191 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="CR13">13</xref>
###xml 870 885 <span type="species:ncbi:10090">transgenic mice</span>
It seems plausible that an enhanced CD36-mediated LCFA uptake rate may contribute to the development of cardiac contractile dysfunction. An increased supply of LCFA may influence excitation-contraction coupling as well as other processes linked to cellular Ca2+ handling [37, 38]. Furthermore, triacylglycerol accumulation is strongly linked to cardiac insulin resistance and contractile dysfunction [1, 2, 8]. The dynamic equilibrium between triacylglycerol stores and triacylglycerol metabolites causes accumulation of ceramide and diacylglycerol during prolonged LCFA influx. Both ceramide and diacylglycerol have been implicated in the activation of serine/threonine kinases, such as PKC, Jun N terminal kinase (JNK), and inhibitor of nuclear factor-kappaB kinase (IKK), which counteract insulin signalling [39, 40]. Notably, chronic myocardial activation of Akt in transgenic mice has also been linked to feedback inhibition of PI3K activity [33] and blunted insulin stimulation of glucose uptake [35]. Importantly, reduced insulin responsiveness reduces the ability of insulin to regulate substrate handling, e.g. metabolic inflexibility [41]. In this study and previous reports [2, 13], we show that HFD feeding reduces insulin responsiveness and impairs metabolic flexibility, as illustrated by the blunted effects of insulin on the stimulation of glucose uptake, phosphorylation of PRAS40, LCFA uptake and translocation of CD36 to the sarcolemma.
###end p 61
###begin p 62
###xml 32 36 <span type="species:ncbi:10116">rats</span>
We conclude that HFD feeding in rats induces cardiac contractile dysfunction, which is preceded by relocation of CD36 to the sarcolemma, and elevated basal levels of phosphorylated PKB/Akt. The continuous presence of CD36 at the sarcolemma contributes to enhanced rates of fatty acid uptake, resulting in myocardial triacylglycerol accumulation and accompanying insulin resistance. Collectively, these data suggest that alterations in the subcellular localisation of CD36 may contribute to the development of diabetes-related heart disease and that CD36 may be a therapeutic target to prevent cardiac dysfunction and the development of heart failure in diabetes.
###end p 62
###begin title 63
Electronic supplementary material
###end title 63
###begin p 64
Below is the link to the electronic supplementary material. 
###end p 64
###begin p 65
###xml 33 37 <span type="species:ncbi:10116">rats</span>
Heart rate and blood pressure of rats after 10 weeks on an HFD or a LFD (PDF 22 kb)
###end p 65
###begin title 66
Acknowledgements
###end title 66
###begin p 67
The authors acknowledge the support of the Dutch Diabetes Research Foundation (grants 2003.00.029 and 2004.00.052), the Netherlands Heart Foundation (NHF grants 2000.156 and 2002.T049), the Netherlands Organisation for Health Research and Development (NWO ZonMw grant 40-00812-98-03075), and the European Commission (Integrated Project LSHM-CT-2004-005272, Exgenesis). JFCG is the NHF Professor of Cardiac Metabolism. JJFPL is the recipient of a VIDI-Innovational Research Grant from the Netherlands Organization of Scientific Research (NWO-ZonMW Grant 016.036.305).
###end p 67
###begin p 68
###xml 0 19 0 19 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Duality of interest</bold>
Duality of interest The authors declare that there is no duality of interest associated with this manuscript.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications
###end article-title 70
###begin article-title 71
###xml 105 109 <span type="species:ncbi:10116">rats</span>
Cardiac dysfunction induced by high-fat diet is associated with altered myocardial insulin signalling in rats
###end article-title 71
###begin article-title 72
###xml 33 37 <span type="species:ncbi:10116">rats</span>
###xml 56 61 <span type="species:ncbi:9606">human</span>
Lipotoxic heart disease in obese rats: implications for human obesity
###end article-title 72
###begin article-title 73
###xml 87 91 <span type="species:ncbi:10090">mice</span>
Altered metabolism causes cardiac dysfunction in perfused hearts from diabetic (db/db) mice
###end article-title 73
###begin article-title 74
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Cardiac lipid accumulation associated with diastolic dysfunction in obese mice
###end article-title 74
###begin article-title 75
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Impaired cardiac efficiency and increased fatty acid oxidation in insulin-resistant ob/ob mouse hearts
###end article-title 75
###begin article-title 76
The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus
###end article-title 76
###begin article-title 77
Adaptation and maladaptation of the heart in diabetes: Part I: general concepts
###end article-title 77
###begin article-title 78
###xml 104 108 <span type="species:ncbi:10116">rats</span>
Enhanced sarcolemmal FAT/CD36 content and triacylglycerol storage in cardiac myocytes from obese Zucker rats
###end article-title 78
###begin article-title 79
The subcellular compartmentation of fatty acid transporters is regulated differently by insulin and by AICAR
###end article-title 79
###begin article-title 80
Long-chain fatty acid uptake and FAT/CD36 translocation in heart and skeletal muscle
###end article-title 80
###begin article-title 81
CD36 Deficiency rescues lipotoxic cardiomyopathy
###end article-title 81
###begin article-title 82
###xml 133 137 <span type="species:ncbi:10116">rats</span>
Insulin-mediated phosphorylation of the proline-rich Akt substrate PRAS40 is impaired in insulin target tissues of high-fat diet-fed rats
###end article-title 82
###begin article-title 83
###xml 65 68 <span type="species:ncbi:10116">rat</span>
Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling
###end article-title 83
###begin article-title 84
###xml 75 79 <span type="species:ncbi:10116">rats</span>
Uptake and metabolism of palmitate by isolated cardiac myocytes from adult rats: involvement of sarcolemmal proteins
###end article-title 84
###begin article-title 85
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
A novel model of cryoinjury-induced myocardial infarction in the mouse: a comparison with coronary artery ligation
###end article-title 85
###begin article-title 86
###xml 98 102 <span type="species:ncbi:10116">rats</span>
Alterations in cardiac contractile performance and sarcoplasmic reticulum function in sucrose-fed rats is associated with insulin resistance
###end article-title 86
###begin article-title 87
###xml 122 126 <span type="species:ncbi:10116">rats</span>
Validation of echocardiographic and Doppler indexes of left ventricular relaxation in adult hypertensive and normotensive rats
###end article-title 87
###begin article-title 88
###xml 35 38 <span type="species:ncbi:10116">rat</span>
Highly insulin-responsive isolated rat heart muscle cells yielded by a modified isolation method
###end article-title 88
###begin article-title 89
AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36
###end article-title 89
###begin article-title 90
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
Sulfo-N-succinimidyl esters of long chain fatty acids specifically inhibit fatty acid translocase (FAT/CD36)-mediated cellular fatty acid uptake
###end article-title 90
###begin article-title 91
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Insulin stimulates long-chain fatty acid utilization by rat cardiac myocytes through cellular redistribution of FAT/CD36
###end article-title 91
###begin article-title 92
###xml 71 76 <span type="species:ncbi:9606">human</span>
Subcellular immunolocalisation of fatty acid translocase (FAT)/CD36 in human type-1 and type-2 skeletal muscle fibres
###end article-title 92
###begin article-title 93
Immunohistochemical determination of cytosolic cytochrome C concentration in cardiomyocytes
###end article-title 93
###begin article-title 94
Role of the alpha2-isoform of AMP-activated protein kinase in the metabolic response of the heart to no-flow ischemia
###end article-title 94
###begin article-title 95
Signalling components involved in contraction-inducible substrate uptake into cardiac myocytes
###end article-title 95
###begin article-title 96
###xml 132 137 <span type="species:ncbi:9606">human</span>
Mitochondrial long chain fatty acid oxidation, fatty acid translocase/CD36 content and carnitine palmitoyltransferase I activity in human skeletal muscle during aerobic exercise
###end article-title 96
###begin article-title 97
Coimmunoprecipitation of FAT/CD36 and CPT I in skeletal muscle increases proportionally with fat oxidation after endurance exercise training
###end article-title 97
###begin article-title 98
Diabetic cardiomyopathy: the search for a unifying hypothesis
###end article-title 98
###begin article-title 99
###xml 72 76 <span type="species:ncbi:10116">rats</span>
Cardiovascular and renal responses to a high-fat diet in Osborne-Mendel rats
###end article-title 99
###begin article-title 100
Akt1 in the cardiovascular system: friend or foe?
###end article-title 100
###begin article-title 101
###xml 59 64 <span type="species:ncbi:9606">human</span>
Differential activation of signal transduction pathways in human hearts with hypertrophy vs advanced heart failure
###end article-title 101
###begin article-title 102
PI3K rescues the detrimental effects of chronic Akt activation in the heart during ischemia/reperfusion injury
###end article-title 102
###begin article-title 103
Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway
###end article-title 103
###begin article-title 104
Effects of chronic Akt activation on glucose uptake in the heart
###end article-title 104
###begin article-title 105
Protein kinase B/Akt signalling is required for palmitate-induced beta-cell lipotoxicity
###end article-title 105
###begin article-title 106
Effects of fatty acids on Na+-Ca2+ exchange and Ca2+ permeability of cardiac sarcolemmal vesicles
###end article-title 106
###begin article-title 107
Long-chain fatty acids activate calcium channels in ventricular myocytes
###end article-title 107
###begin article-title 108
Role of endoplasmic reticulum stress and c-Jun NH2-terminal kinase pathways in inflammation and origin of obesity and diabetes
###end article-title 108
###begin article-title 109
Cellular mechanism of insulin resistance: potential links with inflammation
###end article-title 109
###begin article-title 110
Linking gene expression to function: metabolic flexibility in the normal and diseased heart
###end article-title 110
###begin title 111
Abbreviations
###end title 111
###begin p 112
acetyl-coenzyme A carboxylase
###end p 112
###begin p 113
AMP kinase
###end p 113
###begin p 114
end diastole
###end p 114
###begin p 115
end diastolic diameter
###end p 115
###begin p 116
end diastolic volume
###end p 116
###begin p 117
ejection fraction
###end p 117
###begin p 118
end systole
###end p 118
###begin p 119
end systolic diameter
###end p 119
###begin p 120
end systolic volume
###end p 120
###begin p 121
fractional shortening
###end p 121
###begin p 122
high-fat diet
###end p 122
###begin p 123
interventricular septum wall thickness
###end p 123
###begin p 124
long-chain fatty acid
###end p 124
###begin p 125
low-fat diet
###end p 125
###begin p 126
left ventricle
###end p 126
###begin p 127
phosphatidylinositol 3'-kinase
###end p 127
###begin p 128
protein kinase B
###end p 128
###begin p 129
###xml 43 48 43 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">&#945;</italic>
peroxisome proliferator activated receptor alpha
###end p 129
###begin p 130
proline-rich Akt substrate 40
###end p 130
###begin p 131
posterior wall thickness
###end p 131
###begin p 132
###xml 6 7 6 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
sulfo-N-succinimidyloleate
###end p 132
###begin p 133
left ventricular diameter
###end p 133
###begin p 134
###xml 0 33 0 33 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Electronic supplementary material</bold>
Electronic supplementary material
###end p 134
###begin p 135
The online version of this article (doi:10.1007/s00125-007-0735-8) contains supplementary material, which is available to authorised users.
###end p 135

